# Chapter 126: Major or Mild Vascular Neurocognitive Disorder

## The Biological and Neurological Basis of Major or Mild Vascular Neurocognitive Disorder

### Introduction

Major or Mild Vascular Neurocognitive Disorder (VND), a term encompassing what has traditionally been known as vascular dementia (VaD), represents a spectrum of cognitive impairments caused by cerebrovascular disease (CVD) (Ihara, 2009; Wierenga & Bondi, 2011). This clinical syndrome is defined by a pattern of cognitive deficits that are attributable to one or more cerebrovascular events, such as ischemic or hemorrhagic strokes, or to conditions that affect blood vessels and nerve fibers deep within the brain (Wierenga & Bondi, 2011; Series & Esiri, 2012; Ihara, 2016). The clinical presentation ranges from mild cognitive impairment (MCI), where deficits do not significantly interfere with daily functioning, to major neurocognitive disorder, or dementia, where cognitive losses are severe enough to impact social and occupational independence (Palmer et al., 2022; Ihara, 2009). VND is considered the second most common cause of dementia after Alzheimer's disease (AD), and its prevalence is expected to rise with the aging global population (Moretti et al., 2005; Sova et al., 2009; Wahlund, 2006).

From a biological perspective, VND is not a single, uniform disease but a heterogeneous group of disorders with diverse underlying pathologies (Series & Esiri, 2012; Desmond et al., 1999). The nature of the cognitive syndrome is highly dependent on the location, severity, and type of vascular brain injury (Bogolepova, 2020; Desmond et al., 1999). For instance, dementia resulting from a neurodegenerative process like AD typically involves an insidious onset with gradual cognitive decline, whereas VND often presents with an abrupt onset of symptoms that may remain static or show a stepwise decline corresponding to subsequent cerebrovascular accidents (Wierenga & Bondi, 2011; Strub, 2003). However, this classic distinction is often blurred, as many patients exhibit a gradual, progressive course, particularly when the underlying pathology is cerebral small vessel disease (SVD) (Knopman, 2017; Grishina & Lokshina, 2021). The neuropathological basis can range from multiple large-vessel cortical infarcts to strategic single infarcts in eloquent brain regions, extensive subcortical ischemic lesions, or hemorrhagic damage (Wierenga & Bondi, 2011; Renjen et al., 2023; Zhang & Lim, 2024).

A significant challenge in the study and diagnosis of VND is its frequent coexistence with other neurodegenerative pathologies, most notably AD (Series & Esiri, 2012; Nucera & Hachinski, 2017). This "mixed dementia" is common in the elderly, where vascular and degenerative changes may synergistically contribute to cognitive decline (Wright et al., 2006; Testai & Gorelick, 2010; Attems & Jellinger, 2013). The presence of CVD can magnify the clinical impact of AD pathology, and vice versa, suggesting shared pathogenic mechanisms or a complex interplay between vascular injury and neurodegeneration (Testai & Gorelick, 2010; Caratozzolo et al., 2016; Nucera & Hachinski, 2017). This overlap complicates the delineation of a pure vascular etiology and has led some to argue that the diagnosis of VaD is often made too readily (Brust, 1988). Despite these diagnostic challenges, understanding the distinct and overlapping biological mechanisms of VND is critical. Unlike many neurodegenerative dementias for which only symptomatic treatments are available, the progression of VND may be slowed or prevented through aggressive management of vascular risk factors such as hypertension (Moretti et al., 2005; Gustafson & Skoog, 2009; Grishina & Lokshina, 2021). This chapter will provide a comprehensive overview of the biological and neurological foundations of VND, exploring the implicated neurotransmitter systems, neural circuits, genetic and molecular pathways, and structural and functional brain changes that define this complex disorder.

### Neurobiological Systems

The cognitive and behavioral manifestations of Vascular Neurocognitive Disorder arise from the disruption of intricate neurobiological systems, primarily through ischemic or hemorrhagic damage to neural tissue (Wierenga & Bondi, 2011; Zhang & Lim, 2024). This damage compromises neurotransmitter pathways, disrupts critical neural circuits, and impairs the functional connectivity that underpins higher-order cognition (Moretti et al., 2005; Tay et al., 2021).

#### Neurotransmitter Systems and Neuropharmacology

Vascular brain injury can lead to widespread dysfunction in multiple neurotransmitter systems, contributing to both cognitive and neuropsychiatric symptoms (Moretti et al., 2005; Starkstein & Robinson, 1989). One of the most consistently implicated systems in dementia syndromes, including VND, is the cholinergic system (Moretti et al., 2005). Patients with VaD have been shown to exhibit cholinergic deficits, which may contribute to the characteristic clinical syndromes observed, such as executive dysfunction and behavioral problems (Moretti et al., 2005). This finding provides a rationale for the exploration of cholinesterase inhibitors as a symptomatic treatment, although success has been modest (Strub, 2003; Moretti et al., 2005).

The monoaminergic systems—including dopamine, norepinephrine, and serotonin—are also significantly affected, primarily contributing to the prominent neuropsychiatric features of VND (Starkstein & Robinson, 1989; Alexopoulos, 1997). The concept of "vascular depression" posits that cerebrovascular disease can predispose, precipitate, or perpetuate depressive syndromes in the elderly by disrupting frontal-subcortical circuits that regulate mood (Alexopoulos, 1997; Naarding, 2005; Lebert, 2004). This hypothesis is supported by the high comorbidity of depression and CVD (Starkstein & Robinson, 1989; Halaris, 2009). The underlying mechanisms are thought to involve dysfunction of noradrenergic and serotonergic pathways (Ressler & Nemeroff, 2000; Leonard, 2002; Mann, 2013). Ischemic lesions in the left frontal cortex or left basal ganglia are strongly associated with major depression after stroke, potentially due to disruption of ascending monoaminergic pathways (Starkstein & Robinson, 1989; Robinson, 2000). The clinical presentation of vascular depression often includes a prevalence of motivational problems, anhedonia, and fatigue, which may be linked to disruptions in these neurotransmitter systems (Grool, 2012; Abduraimova et al., 2018).

Dopaminergic pathways, particularly the mesocortical and mesolimbic systems, are also vulnerable. Dysfunction in these circuits is thought to underlie symptoms of apathy, a common and debilitating feature of VND characterized by a reduction in goal-directed behavior (Tay et al., 2021; Ducharme et al., 2017). Apathy is frequently associated with lesions in the dorsolateral prefrontal cortex, anterior cingulate, and orbitofrontal cortex, all of which receive significant dopaminergic input (Ducharme et al., 2017; Tay et al., 2021). Furthermore, disruption of the nigrostriatal dopamine system by subcortical infarcts can produce vascular parkinsonism, a motor syndrome that often co-occurs with cognitive impairment (Vizcarra et al., 2015; Emre, 2003).

Finally, excitatory amino acid neurotransmitters, particularly glutamate, play a critical role in the acute pathophysiology of ischemic injury (Volpe, 1997). The ischemic cascade involves excessive glutamate release, leading to excitotoxicity and neuronal death, a process that initiates the brain damage underlying VND (Kalimo & Smith, 1986; Martin, 2002). This acute neurochemical disruption can trigger a cascade of delayed neuronal degeneration in regions distant from the initial infarct, further expanding the scope of brain dysfunction (Volpe, 1997).

#### Brain Regions, Neural Circuits, and Functional Connectivity

The cognitive syndrome of VND is fundamentally a disconnection syndrome, where vascular lesions disrupt the structural and functional integrity of large-scale neural networks (Bogolepova, 2020; Desmond et al., 1999). The most consistently implicated networks are the frontal-subcortical circuits, which connect the prefrontal cortex with the basal ganglia and thalamus (Jankowicz et al., 1998; Ducharme et al., 2017). These loops are critical for executive functions, including planning, sequencing, cognitive flexibility, and attention—the cognitive domains most characteristically impaired in subcortical VND (Desmond et al., 1999; Moretti et al., 2005; Kwon, 2012).

Subcortical ischemic vascular dementia, often associated with lacunar infarcts and extensive white matter disease (leukoaraiosis), results from the disruption of these pathways (Loeb, 1989; Gustafson & Skoog, 2009; Filley & Brodtmann, 2011). Damage to the white matter tracts deafferents cortical areas from their subcortical inputs, leading to a dysexecutive syndrome and psychomotor slowing (Jankowicz et al., 1998; Bogolepova, 2020; Werring & Camicioli, 2016). This pattern of cognitive deficit is often contrasted with the prominent memory and language deficits typical of cortical dementias like AD (Desmond et al., 1999; Albert et al., 1974).

Strategic infarct dementia underscores the importance of lesion location, where a single, small infarct in a critical hub can produce significant cognitive impairment (Renjen et al., 2023). For example, lesions in the thalamus can cause severe memory and executive deficits by disrupting its role as a relay station within cortico-subcortical circuits (Rusconi et al., 2013; Renjen et al., 2023). Similarly, infarcts in the head of the caudate nucleus have been linked to abulia, apathy, and executive dysfunction (Starkstein & Robinson, 1989; Santos et al., 2009). Infarctions affecting the vertebrobasilar circulation can specifically impair recent memory and visual-spatial functioning by damaging the thalamus, hippocampus, and occipital lobes (Koçer, 2015; Barton & Caplan, 2012).

Beyond focal lesions, the global burden of cerebrovascular pathology contributes to widespread network dysfunction. Neuroinflammation, endothelial dysfunction, and impaired neurovascular coupling—the mechanism that matches local cerebral blood flow to neuronal activity—are increasingly recognized as key pathophysiological processes (Najjar et al., 2013; Epps & Allen, 2017; Unknown, 2016). These processes lead to a state of chronic cerebral hypoperfusion, which can cause diffuse neuronal dysfunction and exacerbate the effects of focal ischemic events (Horváth, 2001; Nucera & Hachinski, 2017). Functional neuroimaging studies have demonstrated reduced functional connectivity within key cognitive networks, such as the default mode and frontoparietal networks, in patients with VND (Rayner, 2019). This breakdown in coordinated brain activity likely represents the final common pathway through which diverse vascular pathologies converge to produce the clinical syndrome of major or mild vascular neurocognitive disorder.

### Genetic and Molecular Basis

While often considered an acquired condition linked to lifestyle and age-related risk factors, VND also has significant genetic and molecular underpinnings. These range from rare monogenic disorders that cause severe, early-onset vascular brain injury to the complex interplay of susceptibility genes, inflammatory cascades, and cellular stress responses that mediate the brain's response to ischemia (Gustafson & Skoog, 2009; Nucera & Hachinski, 2017).

#### Genetic Factors and Heritability

The most compelling evidence for a genetic basis of VND comes from hereditary small-vessel diseases. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is the most common form, caused by mutations in the *NOTCH3* gene (Gustafson & Skoog, 2009). This disorder leads to recurrent subcortical ischemic strokes, progressive cognitive decline, and dementia, often with an onset in mid-adulthood (Gustafson & Skoog, 2009). Other familial disorders characterized by subcortical ischemic strokes, dementia, and leukoencephalopathy have also been described, suggesting genetic heterogeneity even among monogenic forms of the disease (Hachinski, 1992). While these conditions are rare, they provide a powerful model for understanding the consequences of pure small-vessel pathology on brain structure and function.

Beyond rare Mendelian disorders, genetic factors also play a role in sporadic VND by influencing susceptibility to key vascular risk factors like hypertension, diabetes, and hyperlipidemia (Testai & Gorelick, 2010; Dhikav et al., 2022). Furthermore, genes involved in inflammation, endothelial function, and lipid metabolism are candidate risk factors for both cerebrovascular disease and cognitive decline. The apolipoprotein E (ApoE) ε4 allele, a major genetic risk factor for AD, has also been implicated in poorer outcomes after stroke and may modulate the relationship between vascular pathology and cognitive impairment, highlighting the genetic overlap between vascular and neurodegenerative pathways (Willroth et al., 2022; Hu & Chen, 2017). The study of familial aggregation of stroke and dementia further supports a heritable component, though the specific genes involved in most cases of sporadic VND remain to be fully elucidated (Hu & Chen, 2017; Cadoret & Winokur, 1972).

#### Molecular and Cellular Mechanisms

At the molecular level, the pathophysiology of VND is driven by the cellular response to cerebral ischemia and hypoperfusion (Hossmann, 1998; Kalimo & Smith, 1986). The ischemic cascade is a complex sequence of events initiated by a reduction in cerebral blood flow (CBF), leading to energy failure, ionic imbalance, and ultimately, neuronal death (Muir et al., 1997; Martin, 2002).

A critical early event is excitotoxicity, where energy depletion impairs the reuptake of the neurotransmitter glutamate, leading to its accumulation in the synaptic cleft (Volpe, 1997). This excessive glutamate overstimulates postsynaptic receptors (particularly NMDA receptors), causing a massive influx of calcium ions (Ca2+) into the neuron. This intracellular calcium overload activates a host of catabolic enzymes, including proteases, lipases, and endonucleases, which degrade cellular components and trigger apoptotic (programmed cell death) and necrotic cell death pathways (Martin, 2002; Volpe, 1997). This process can lead to delayed neuronal degeneration, where neurons distant from the initial ischemic core die days or weeks after the initial insult (Volpe, 1997).

Neuroinflammation is another key molecular process. Ischemia triggers a potent inflammatory response, characterized by the activation of resident microglia and astrocytes and the infiltration of peripheral immune cells into the brain parenchyma (Sonneville et al., 2013; Reis & Castro‐Faria‐Neto, 2022). Activated glial cells release a barrage of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), chemokines, and reactive oxygen species (ROS) (Uzoni et al., 2015; Reis & Castro‐Faria‐Neto, 2022). While initially a protective response, sustained neuroinflammation can be detrimental, contributing to secondary neuronal damage, breakdown of the blood-brain barrier (BBB), and impaired neurogenesis (Sonneville et al., 2013; Adam et al., 2013). This inflammatory state is not confined to the brain; systemic inflammation, often seen in conditions like sepsis or associated with vascular risk factors like atherosclerosis, promotes a chronic pro-inflammatory state that aggravates cerebrovascular pathology (Uzoni et al., 2015; Reis & Castro‐Faria‐Neto, 2022; Adam et al., 2013).

The neurovascular unit (NVU)—comprising neurons, glia, endothelial cells, and pericytes—is a central player in this process. Dysfunction of the NVU is a hallmark of VND (Najjar et al., 2013). Chronic hypoperfusion and inflammatory insults lead to endothelial dysfunction, increased BBB permeability, and impaired neurovascular coupling (Epps & Allen, 2017; Unknown, 2016). This BBB hyperpermeability allows neurotoxic molecules from the blood to enter the brain, further fueling inflammation and neuronal injury (Najjar et al., 2013). Oxidative stress, the imbalance between ROS production and antioxidant defenses, is a common pathway linking vascular risk factors, inflammation, and neuronal damage (Reis & Castro‐Faria‐Neto, 2022). Ultimately, these molecular and cellular events converge to cause both focal neuronal loss from infarcts and diffuse damage to white matter and subcortical structures, leading to the progressive cognitive and functional decline characteristic of VND (Kalimo & Smith, 1986; Martin, 2002).

### Brain Structure and Function

The diagnosis and characterization of Vascular Neurocognitive Disorder are heavily reliant on the identification of structural and functional brain abnormalities, primarily through neuroimaging (Wierenga & Bondi, 2011; Grishina & Lokshina, 2021). The diverse pathologies underlying VND produce a range of findings, from macroscopic infarcts to subtle changes in white matter integrity and cerebral perfusion, which correlate with the heterogeneous clinical presentations of the disorder (Desmond et al., 1999; Knopman, 2017).

#### Neuroimaging Findings (Structural)

Structural neuroimaging, particularly magnetic resonance imaging (MRI), is the cornerstone for establishing a vascular basis for cognitive impairment (Series & Esiri, 2012; Grishina & Lokshina, 2021). The hallmark neuropathological features of VND detectable on imaging include a variety of ischemic and hemorrhagic lesions (Wierenga & Bondi, 2011; Hu & Chen, 2017).

**Cortical and Subcortical Infarcts:** The classic form of "multi-infarct dementia" results from the cumulative effect of multiple, often cortical, strokes (Brust, 1988; Wierenga & Bondi, 2011). However, the location of infarcts is often more critical than the total volume of tissue loss. "Strategic infarct dementia" can arise from a single, small infarct in a functionally critical brain region, such as the thalamus, hippocampus, or caudate nucleus, which disrupts major cognitive networks (Renjen et al., 2023; Carota, 2002).

**Small Vessel Disease (SVD) Markers:** More commonly, VND is associated with markers of cerebral SVD, which reflect damage to the small perforating arteries and arterioles supplying the deep white and gray matter (Bogolepova, 2020; Werring & Camicioli, 2016). The primary imaging manifestations of SVD are:
1.  **Lacunar Infarcts:** These are small (<15 mm) subcortical infarcts in the basal ganglia, thalamus, internal capsule, or pons, resulting from the occlusion of a single penetrating arteriole (Loeb, 1989; Filley & Brodtmann, 2011). While individual lacunes may be clinically silent, their accumulation contributes to a progressive dysexecutive syndrome and gait disturbance, characteristic of subcortical ischemic vascular dementia (Loeb, 1989; Werring & Camicioli, 2016).
2.  **White Matter Hyperintensities (WMH) or Leukoaraiosis:** Seen as high signal intensity on T2-weighted and FLAIR MRI sequences, WMH are extremely common in older adults and are strongly associated with vascular risk factors, particularly hypertension (Bogolepova, 2020; Grishina & Lokshina, 2021). These lesions represent areas of demyelination, axonal loss, and gliosis, likely resulting from chronic hypoperfusion and BBB dysfunction (Series & Esiri, 2012; Grool, 2012). The severity and extent of WMH correlate with cognitive decline, especially in executive function and processing speed (Jiménez Martín et al., 2008; Grool, 2012).
3.  **Cerebral Microbleeds (CMBs):** These are small, rounded signal voids on gradient-echo or susceptibility-weighted imaging sequences, representing focal deposits of hemosiderin from previous microhemorrhages (Werring & Camicioli, 2016). Their presence is another marker of advanced SVD and is associated with an increased risk of both ischemic and hemorrhagic stroke, as well as cognitive impairment (Werring & Camicioli, 2016).

**Cerebral Atrophy:** Generalized and regional brain atrophy is also a common finding in VND (Hu & Chen, 2017). While less specific than ischemic lesions, atrophy reflects the downstream consequence of neuronal and axonal loss. In some cases, particularly when mixed pathology is present, medial temporal lobe atrophy, a hallmark of AD, may be observed, complicating the diagnostic picture (Series & Esiri, 2012; Hu & Chen, 2017). The presence of significant brain atrophy in conjunction with vascular lesions is associated with more severe cognitive impairment (Yao, 2017).

#### Neuroimaging Findings (Functional) and Electrophysiology

Functional neuroimaging techniques provide insights into the physiological consequences of cerebrovascular pathology, often detecting abnormalities even when structural imaging is unremarkable (Koçer, 2015). Techniques like Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) can measure regional cerebral blood flow (rCBF) and metabolism. In VND, these studies often reveal hypoperfusion and hypometabolism, particularly in the frontal lobes and subcortical structures, which aligns with the clinical profile of executive dysfunction (Yamazaki, 2012; Goodwin, 1997). These functional deficits can be more widespread than the structural lesions, reflecting the concept of diaschisis, where a focal lesion causes remote dysfunction in connected brain regions (Markowitsch & Calabrese, 1996).

Advanced MRI techniques also contribute to understanding functional disruption. Diffusion Tensor Imaging (DTI) can detect microstructural damage in white matter tracts not visible on conventional MRI, providing a more sensitive measure of the disconnection underlying cognitive symptoms (Werring & Camicioli, 2016). Functional MRI (fMRI) has been used to investigate alterations in brain network connectivity and can demonstrate impaired neurovascular coupling, the fundamental mechanism by which blood flow is regulated to meet the metabolic demands of active neurons (Epps & Allen, 2017; Unknown, 2016).

Electroencephalography (EEG) is another tool for assessing brain function. In VND, EEG findings are often nonspecific, typically showing diffuse background slowing, which reflects generalized cerebral dysfunction (Kaplan & Rossetti, 2011; Müller & Schwartz, 1978). Focal slowing may be seen over areas of infarction (Kaplan & Rossetti, 2011). While not diagnostic for VND, EEG can be useful for excluding other causes of cognitive impairment, such as nonconvulsive status epilepticus, or for identifying comorbid conditions (Brigo, 2012; Celesia, 1976). Together, these structural and functional measures paint a picture of a brain compromised by vascular injury, characterized by both focal tissue destruction and widespread network dysfunction, which collectively drive the cognitive and behavioral symptoms of VND.

### Developmental Neurobiology

The emergence and clinical expression of Vascular Neurocognitive Disorder across the lifespan are profoundly influenced by developmental factors, particularly the concept of brain and cognitive reserve (Willroth et al., 2022; Nelson et al., 2020). While VND is predominantly a disorder of later life, its trajectory is shaped by the brain's developmental history, its resilience to injury, and the timing of vascular insults (Hu & Chen, 2017; Knopman, 2017). The developing brain has critical periods of vulnerability, and insults during these times can have long-lasting consequences for cognitive function (Stafstrom et al., 2006).

#### Brain Development, Cognitive Reserve, and Vulnerability

The brain's resilience to pathology, often termed "reserve," is built over a lifetime and is influenced by genetic and environmental factors, including early-life education and cognitive stimulation (Willroth et al., 2022; Nelson et al., 2020). A higher cognitive reserve allows an individual to better withstand the clinical impact of brain pathology, including vascular lesions (Nelson et al., 2020). Individuals with higher educational attainment or greater occupational complexity may maintain normal cognitive function despite a significant burden of white matter hyperintensities or lacunar infarcts, delaying the clinical manifestation of dementia (Hu & Chen, 2017; Nelson et al., 2020). Conversely, those with lower reserve may become symptomatic with a lesser degree of vascular pathology (Hu & Chen, 2017). This principle helps explain the substantial individual heterogeneity in the relationship between the severity of cerebrovascular disease on neuroimaging and the degree of clinical cognitive impairment (de Haan et al., 2006; Nelson et al., 2020).

The developmental trajectory of the brain also establishes its vulnerability to specific types of injury. The perinatal period is a time of particular susceptibility to hypoxic-ischemic insults, which serve as a powerful model for understanding the consequences of vascular brain injury (Perlman, 2006; Skullerud, 1994). Perinatal hypoxic-ischemic encephalopathy (HIE) can lead to selective neuronal necrosis and white matter damage, resulting in long-term neurological deficits such as cerebral palsy and cognitive impairment (Folkerth, 2011; Goertchen et al., 1977). The pattern of injury is dependent on the developmental stage of the brain at the time of the insult; for example, the premature brain is particularly vulnerable to periventricular white matter injury (periventricular leukomalacia), a pathology that shares mechanisms with the leukoaraiosis seen in adult VND (Folkerth, 2011; Krägeloh‐Mann, 2010). These early-life vascular injuries can establish a foundation of reduced brain reserve, potentially increasing the risk for clinically significant cognitive decline when further vascular or neurodegenerative pathologies accumulate in later life (Perlman, 2006; Alloway, 2012).

#### Onset Across the Lifespan and Critical Periods

While typically a disease of the elderly, VND can manifest in younger adults, often due to specific etiologies such as genetic disorders (e.g., CADASIL), autoimmune vasculitis, or premature atherosclerosis (Gustafson & Skoog, 2009; Hachinski, 1992; Cojocaru et al., 2010). The clinical presentation in younger individuals may be atypical, sometimes mimicking primary psychiatric or other neurological disorders, which can delay diagnosis (Mendez, 2006; Ahmed et al., 2016).

The concept of critical periods in neurodevelopment suggests that the timing of a vascular insult can determine the nature of the resulting cognitive deficit (Stafstrom et al., 2006). An injury during a period of rapid synaptogenesis or myelination may have more devastating and widespread consequences than a similar injury occurring after these processes are complete (Njiokiktjien, 1994). For example, brain damage sustained in childhood can lead to generalized cognitive impairment rather than the focal deficits often seen in adults, reflecting the disruptive impact on a still-organizing brain (Vargha‐Khadem, 2001).

Furthermore, the aging process itself represents a critical period of declining neuroplasticity and increasing vulnerability. Age-related changes in the vasculature, such as arterial stiffness and endothelial dysfunction, lower the threshold for ischemic injury (Lima, 2018; Semplicini & Inverso, 2008). Moreover, the aging brain has a diminished capacity for repair and compensation, meaning that recovery from a stroke is often less complete in older individuals (Hu & Chen, 2017). The interaction between normal aging processes and cerebrovascular pathology is therefore a key determinant of the onset and progression of VND (Berchtold & Cotman, 2008). The accumulation of vascular risk factors over decades culminates in a state of heightened vulnerability in later life, where even minor ischemic events can tip the balance from compensated brain function to clinically manifest cognitive impairment (Testai & Gorelick, 2010; Gustafson & Skoog, 2009).

### Treatment Mechanisms

The management of Major or Mild Vascular Neurocognitive Disorder is multifaceted, focusing on prevention of further vascular injury, symptomatic treatment of cognitive and behavioral disturbances, and rehabilitation (Moretti et al., 2005; Grishina & Lokshina, 2021). Unlike neurodegenerative dementias where disease-modifying therapies are largely unavailable, the vascular nature of VND offers a critical opportunity for intervention by targeting the underlying cerebrovascular pathology and its risk factors (Gustafson & Skoog, 2009; Testai & Gorelick, 2010).

#### Primary and Secondary Prevention: Targeting Vascular Risk Factors

The cornerstone of VND management is the aggressive control of vascular risk factors to prevent initial or recurrent cerebrovascular events (Moretti et al., 2005; Hu & Chen, 2017). This approach is based on the robust epidemiological link between factors like hypertension, diabetes mellitus, hyperlipidemia, and smoking, and the development of both stroke and dementia (Testai & Gorelick, 2010; Dhikav et al., 2022; Gustafson & Skoog, 2009).

**Antihypertensive Therapy:** Hypertension is arguably the most significant modifiable risk factor for VND (Lima, 2018; Abduraimova et al., 2018). It promotes cerebral small vessel disease, leading to lacunar infarcts and leukoaraiosis (Bogolepova, 2020). Antihypertensive treatment has been shown to reduce the risk of stroke and may also slow cognitive decline (Semplicini & Inverso, 2008; Захаров et al., 2024). The mechanisms involve reducing hemodynamic stress on cerebral vessels, improving endothelial function, and attenuating arterial stiffness, thereby preserving cerebral perfusion and microvascular integrity (Lima, 2018; Semplicini & Inverso, 2008).

**Management of Diabetes and Hyperlipidemia:** Diabetes mellitus contributes to neuropathy and microvascular damage throughout the body, including the brain (Pirart, 1965; Kempler, 2002). Strict glycemic control is essential for preventing microvascular complications (Bansal et al., 2006). Similarly, managing hyperlipidemia with statins reduces atherosclerosis and the risk of ischemic stroke, which are foundational events in the development of VND (Testai & Gorelick, 2010).

**Antiplatelet and Anticoagulant Therapy:** For secondary stroke prevention, antiplatelet agents (e.g., aspirin) are standard care for non-cardioembolic ischemic stroke (Saadatnia et al., 2012). In cases of cardioembolic stroke, such as those associated with atrial fibrillation, oral anticoagulation is crucial to prevent recurrent events and further cognitive decline (Sanna et al., 2008).

#### Symptomatic Pharmacological Treatments

While prevention is key, several pharmacological strategies aim to ameliorate the cognitive and neuropsychiatric symptoms of established VND.

**Cholinesterase Inhibitors and Memantine:** Based on evidence of cholinergic deficits in some patients with VaD, cholinesterase inhibitors (e.g., donepezil), which are standard treatment for AD, have been studied in VND (Moretti et al., 2005). The rationale is that by increasing synaptic acetylcholine levels, these drugs may enhance cognitive function, particularly attention and executive function (Moretti et al., 2005). Similarly, memantine, an NMDA receptor antagonist, has also been explored (Jiménez Martín et al., 2008). However, the benefits of these agents in pure VND are generally considered modest and less consistent than in AD (Strub, 2003; Moretti et al., 2005).

**Antidepressants and Antipsychotics:** Neuropsychiatric symptoms such as depression, apathy, and psychosis are common and distressing features of VND (Nagaratnam & Pathma‐Nathan, 1997; Alexopoulos, 1997). Selective serotonin reuptake inhibitors (SSRIs) are often used to treat post-stroke depression and may improve mood and overall function (Starkstein & Robinson, 1989; Carota, 2002). Atypical antipsychotics may be required for severe agitation or psychosis, but their use must be cautious due to potential side effects and increased mortality risk in the elderly (Soriano-Barceló et al., 2012).

#### Neuroprotective and Regenerative Strategies

**Neuroprotection:** A major focus of acute stroke research has been neuroprotection—interventions aimed at salvaging ischemic brain tissue by interrupting the ischemic cascade (Jain, 2011; Jain, 2019). Strategies have targeted mechanisms like excitotoxicity, inflammation, and oxidative stress (Volpe, 1997; Reis & Castro‐Faria‐Neto, 2022). While many agents have failed in clinical trials for acute stroke, the concept of ongoing neuroprotection in the context of chronic cerebral hypoperfusion remains an area of interest (Horváth, 2001). For instance, drugs with multimodal actions, such as improving cerebral blood flow and providing antioxidant effects, are considered potentially beneficial (Grishina & Lokshina, 2021; Horváth, 2001).

**Neuroplasticity and Rehabilitation:** The brain retains a capacity for plasticity and reorganization even after significant injury. Non-pharmacological approaches are vital for maximizing functional recovery. Cognitive rehabilitation and training can help patients develop compensatory strategies to cope with deficits in memory, attention, and executive function (Grishina & Lokshina, 2021; Tay et al., 2021). Physical activity is also crucial, as it not only improves cardiovascular health but may also promote neurogenesis and enhance cognitive function (Grishina & Lokshina, 2021). Emerging research into cell-based therapies, which aim to replace neurons lost to ischemia, represents a future frontier, though significant challenges remain in translating these experimental approaches to clinical practice (Kopach & Pivneva, 2018).

### Future Directions

The field of Vascular Neurocognitive Disorder is evolving rapidly, driven by advances in neuroimaging, molecular biology, and a growing appreciation for the intricate relationship between vascular health and brain function. Despite significant progress, many questions remain unanswered, pointing to several critical areas for future research.

One of the most pressing challenges is the need for refined diagnostic criteria and biomarkers to better differentiate VND from AD and, particularly, to accurately characterize mixed pathologies (Desmond et al., 1999; Series & Esiri, 2012; Nucera & Hachinski, 2017). The clinical and pathological overlap between VND and AD is substantial, and current diagnostic schemes often struggle to disentangle their respective contributions to a patient's cognitive decline (Series & Esiri, 2012; Wright et al., 2006). Future research should focus on developing and validating advanced neuroimaging techniques and fluid biomarkers that can specifically identify vascular-mediated neuronal injury versus neurodegenerative processes (Nucera & Hachinski, 2017). For example, imaging markers of endothelial dysfunction, BBB permeability, or neuroinflammation may provide more direct evidence of a vascular contribution to cognitive impairment than current measures of chronic ischemic change (Najjar et al., 2013; Lövblad et al., 2019).

Understanding the longitudinal progression of VND is another key priority. Most studies are cross-sectional, providing only a snapshot of the disease. Prospective, long-term cohort studies are essential to map the trajectory of cognitive decline in different VND subtypes, identify predictors of progression, and clarify the temporal relationship between vascular events and cognitive symptoms (Hu & Chen, 2017; Zhang & Lim, 2024). Such studies are crucial for determining critical windows for intervention and for designing more effective clinical trials (Desmond et al., 1999).

Elucidating the precise molecular and cellular mechanisms linking vascular risk factors to neuronal dysfunction and cognitive impairment is fundamental. While the roles of hypoperfusion, inflammation, and excitotoxicity are broadly understood, the specific pathways that mediate the transition from asymptomatic cerebrovascular disease to clinical cognitive impairment are still being explored (Reis & Castro‐Faria‐Neto, 2022; Volpe, 1997). Research into the function of the neurovascular unit, the role of pericyte injury, and the interplay between systemic and central inflammation will likely yield novel therapeutic targets (Najjar et al., 2013; Uzoni et al., 2015). For instance, therapies aimed at restoring BBB integrity or modulating microglial activation could offer new avenues for neuroprotection (Sonneville et al., 2013).

The development of more effective treatments remains a central goal. Beyond primary and secondary stroke prevention, there is a need for therapies that can improve cognition and function in patients with established VND. This includes exploring novel pharmacological agents that target specific pathophysiological mechanisms, such as neuroinflammation or impaired neurovascular coupling (Grishina & Lokshina, 2021; Epps & Allen, 2017). Furthermore, innovative approaches to neurorehabilitation and plasticity are warranted. Cell-based therapies, aiming to replace damaged neural tissue or provide trophic support, represent a long-term but promising direction (Kopach & Pivneva, 2018). Non-invasive brain stimulation techniques are also being investigated for their potential to enhance cognitive rehabilitation and promote adaptive neuroplasticity (Lara-Plaza et al., 2022).

Finally, a greater focus on the heterogeneity of VND is needed. The disorder encompasses a wide range of pathologies, from large vessel disease to hereditary arteriopathies like CADASIL (Gustafson & Skoog, 2009). Future research must move beyond a monolithic view of "vascular dementia" and stratify patients based on underlying pathophysiology, lesion location, and genetic background. This personalized approach will be essential for developing targeted therapies and for ultimately reducing the immense personal and societal burden of this devastating condition.

### Conclusion

Major or Mild Vascular Neurocognitive Disorder represents a significant and growing public health challenge, rooted in the complex and damaging interplay between cerebrovascular disease and brain function. It is not a single disease but a heterogeneous syndrome, the clinical expression of which is dictated by the nature, location, and extent of underlying vascular pathology (Desmond et al., 1999; Series & Esiri, 2012). The biological basis of VND is multifactorial, involving a cascade of events initiated by cerebral ischemia, hemorrhage, or chronic hypoperfusion (Wierenga & Bondi, 2011; Hossmann, 1998). These insults trigger molecular pathways of excitotoxicity, neuroinflammation, and oxidative stress, leading to dysfunction of the neurovascular unit, breakdown of the blood-brain barrier, and ultimately, neuronal death and disconnection of critical neural circuits (Volpe, 1997; Najjar et al., 2013; Martin, 2002).

The resulting cognitive profile is often characterized by a prominent dysexecutive syndrome, psychomotor slowing, and attentional deficits, reflecting the vulnerability of frontal-subcortical networks to vascular injury (Desmond et al., 1999; Moretti et al., 2005). Neuroimaging plays a crucial role in diagnosis, revealing characteristic markers such as cortical infarcts, subcortical lacunes, and diffuse white matter hyperintensities (Grishina & Lokshina, 2021; Filley & Brodtmann, 2011). However, the frequent coexistence of vascular lesions with neurodegenerative pathologies, particularly Alzheimer's disease, creates significant diagnostic ambiguity and highlights a synergistic relationship between these disease processes (Nucera & Hachinski, 2017; Attems & Jellinger, 2013).

Despite the complexity of its pathophysiology, the vascular basis of VND offers a crucial window for therapeutic intervention. The most effective strategy currently available is the rigorous management of vascular risk factors, including hypertension, diabetes, and hyperlipidemia, to prevent further cerebrovascular events (Moretti et al., 2005; Gustafson & Skoog, 2009). While symptomatic treatments for cognitive and behavioral symptoms exist, their efficacy is modest (Strub, 2003). The future of VND research lies in refining diagnostic tools to better characterize disease subtypes, elucidating specific molecular targets within the ischemic cascade, and developing novel neuroprotective and restorative therapies. Ultimately, a deeper understanding of the biological mechanisms underlying VND reinforces a fundamental principle of modern neurology and geriatrics: the preservation of cognitive health is inextricably linked to the maintenance of cardiovascular and cerebrovascular integrity.

## References

1. Aa, S., An, K., Va, K., Sa, K., Ie, V., Mn, P., & Ms, L. (1994). [Immunological reactivity and nonspecific resistance in the early posttraumatic period in victims with closed craniocerebral trauma].. PubMed.
2. Ab, S., Al, S., VIa, G., NIu, K., & Mo, L. (1989). [Problem of "organic neuroses" (data on functional disorders of cardiac activity)].. PubMed.
3. Abdul‐Khaliq, H., Schubert, S., Stoltenburg-Didinger, G., Hübler, M., Böttcher, W., Triotzsch, D., Hetzer, R., & Lange, P. (2000). Early immunohistochemical brain overexpression of S-100β and increased serum level after deep hypothermic circulatory arrest in rabbits: relationship to perivascular astrocytic swelling. Critical Care. https://doi.org/10.1186/cc674
4. Abduraimova, S. K. (2018). Cognitive, emotional, and behavioral disorders in hypertensive patients. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2018-4-116-122
5. Abel, F. L. (1989). Myocardial function in sepsis and endotoxin shock. AJP Regulatory Integrative and Comparative Physiology. https://doi.org/10.1152/ajpregu.1989.257.6.r1265
6. Adam, M. P., Conta, J. H., & Bean, L. J. (2013). Mowat-Wilson Syndrome.
7. Adam, N., Kandelman, S., Mantz, J., Chrétien, F., & Sharshar, T. (2013). Sepsis-induced brain dysfunction. Expert Review of Anti-infective Therapy. https://doi.org/10.1586/eri.12.159
8. Adler, C. M., DelBello, M. P., & Strakowski, S. M. (2006). Brain Network Dysfunction in Bipolar Disorder. CNS Spectrums. https://doi.org/10.1017/s1092852900020800
9. Agapejev, S., Silva, M. D. D., & Resende, L. A. D. L. (1996). Pourradiculoneurite e neurocisticercose: relato de caso. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x1996000100018
10. Ahmed, S., Baker, I., & Butler, C. (2016). Diagnosing young onset dementia can be challenging.. PubMed.
11. Akbarzadeh, M., Akbarzadeh, R., & Akbarzadeh, R. (2006). Correlating brain atrophy with cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiologic findings. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-5-s1-s267
12. Akyol, A., Kıylıoğlu, N., Bölükbaşı, O., Güney, E., & YÜREKLİ, Y. D. D. V. (2003). Repeated hypoglycemia and cognitive decline. A case report.. PubMed.
13. Albert, M. L., Feldman, R. G., & Willis, A. (1974). The `subcortical dementia' of progressive supranuclear palsy. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.37.2.121
14. Alberti, O., Santos, S., Corbalán, T., & Cortina, M. T. (2009). [Stroke-psychosis. Description of two cases].. PubMed.
15. Albrecht, B., Sandersleben, H. U.-V., Gevensleben, H., & Rothenberger, A. (2015). Pathophysiology of ADHD and associated problems—starting points for NF interventions?. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2015.00359
16. Alexopoulos, G. S. (1997). 'Vascular Depression' Hypothesis. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1997.01830220033006
17. Allen, D. N., Sprenkel, D. G., Heyman, R., Schramke, C. J., & Heffron, N. E. (1998). Evaluation of Demyelinating and Degenerative Disorders. Neuropsychology. https://doi.org/10.1007/978-1-4899-1950-2_9
18. Alloway, T. P. (2012). The profile of executive function of very preterm children at 4 to 12 years. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04197.x
19. Almakhanova, K. K., Nurguzhaev, E. S., Nurzhanova, R., Demesinova, B., Mukasheva, T. Z., & Stepuk, N. V. (2022). Idiopathic longitudinally extensive myelitis: a brief historical excursion (review) and own clinical observation. Journal of clinical practice. https://doi.org/10.17816/clinpract100341
20. Alvira-Duplá, M. R., & Mayayo-Artal, E. (2000). Síndromes paraneoplásicos con afectación nerviosa periférica. Revista de Neurología. https://doi.org/10.33588/rn.3112.2000244
21. Amado, C., Duarte, V., Leal, M. S., Cruz, M., & Ferreira, G. (2021). Chronic Lymphocytic Leukaemia: Rare Involvement of the Central Nervous System. European Journal of Case Reports in Internal Medicine. https://doi.org/10.12890/2021_002847
22. Ana, A., Raluca, Sandu, Fragaki, M., Buga, Adriana, A., Uzoni, Eugen, Bogdan, Petcu, Aurel, & Popa‐Wagner (2015). Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. 中国神经再生研究：英文版.
23. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
24. Andreisek, G., Crook, D. W., Burg, D., Marinček, B., & Weishaupt, D. (2006). Peripheral Neuropathies of the Median, Radial, and Ulnar Nerves: MR Imaging Features. Radiographics. https://doi.org/10.1148/rg.265055712
25. Antunes, A., Dias, M. C., & Verdelho, A. (2016). Neuropsychiatric Symptoms in Reversible Dementias. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_6
26. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
27. Arbour, R. (2013). Brain Death: Assessment, Controversy, and Confounding Factors. Critical Care Nurse. https://doi.org/10.4037/ccn2013215
28. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
29. Arkhipenko, I. V., & Gulyaev, S. A. (2015). EPILEPSY IN ELDERLY PATIENTS (DIAGNOSTIC FEATURES). DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.17650/2073-8803-2014-9-2-24-29
30. Arsovska, A., & Uludüz, D. (2022). None. Cambridge University Press eBooks. https://doi.org/10.1017/9781108902793.018
31. Asamoah, K. T., & Dei‐Asamoa, R. (2022). Psychiatry Meets Cardiology: A Case Report on the Need for Mental Health Assessment in the Evaluation of Cardiovascular Symptoms. Case Reports in Psychiatry. https://doi.org/10.1155/2022/5415196
32. Ashton, H. (1992). Disorders of memory. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780192622426.003.0009
33. Attems, J., & Jellinger, K. A. (2013). Neuropathological Correlates of Cerebral Multimorbidity. Current Alzheimer Research. https://doi.org/10.2174/15672050113109990002
34. Atukorala, I., Weeratunga, P., Gunasekera, S. N., Gunawardena, N., & Chang, T. (2013). THU0331 Do EEG Changes in SLE Correlate with SLE Disease Activity?. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2013-eular.859
35. Auer, R. N., Laganière, J., Robitaille, Y., Richardson, J. B., Dion, P. A., Rouleau, G. A., & Shekarabi, M. (2016). KCC3 axonopathy: neuropathological features in the central and peripheral nervous system. Modern Pathology. https://doi.org/10.1038/modpathol.2016.90
36. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
37. Ayerbe, I., & Négrevergne, M. (2005). [Vertigo and pathology of the cerebellospinal system].. PubMed.
38. Badrin, S., Mohamad, N., Yunus, N. A., & Zulkifli, M. M. (2017). A Brief Psychotic Episode with Depressive Symptoms in Silent Right Frontal Lobe Infarct. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.2017.38.6.380
39. Bae, C. H., Na, H. G., & Choi, Y. S. (2021). Current diagnosis and treatment of vestibular neuritis: a narrative review. Journal of Yeungnam Medical Science. https://doi.org/10.12701/yujm.2021.01228
40. Bahtiyarca, Z. T., Karaahmet, Ö. Z., & ÇAKMAK, C. (2021). Postpartum Acute Brachial Plexus Neuritis Mimicking Anterior Interosseous Nerve Palsy. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi. https://doi.org/10.31609/jpmrs.2020-79940
41. Bak, T. H., & Hodges, J. R. (1998). The neuropsychology of progressive supranuclear palsy. Neurocase. https://doi.org/10.1080/13554799808410610
42. Baka, R., & Polizopoulou, Z. (2019). Feline Epilepsy: An Update. Journal of the Hellenic Veterinary Medical Society. https://doi.org/10.12681/jhvms.19887
43. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
44. Balmaceda, C., & Korkin, E. (2003). Cancer and Cancer Treatment-Related Neuromuscular Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-317-0_15
45. Bansal, V., Kalita, J., & Misra, U. K. (2006). Diabetic neuropathy. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2005.036137
46. Barbosa, R., Postal, M., Costallat, L. T. L., Cendes, F., & Appenzeller, S. (2012). Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance. Current Rheumatology Reviews. https://doi.org/10.2174/157339712801318975
47. Barbosa, T. A., Machado, R. R., Moeda, A. S. G., Gloria, I. R., Shidiq, S., & Brandão, P. (2023). Importância da hidrocefalia como diagnóstico diferencial de síndromes demenciais. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.315.5.2018
48. Barclay, L., Weiss, E., Mattis, S., BOND, O. B., & Blass, J. P. (1988). Unrecognized Cognitive Impairment in Cardiac Rehabilitation Patients. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1988.tb03429.x
49. Barkovich, A. J. (1997). The encephalopathic neonate: choosing the proper imaging technique. American Journal of Neuroradiology.
50. Barry, S., Baird, G., Lascelles, K., Bunton, P., & Hedderly, T. (2011). Neurodevelopmental movement disorders - an update on childhood motor stereotypies. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04058.x
51. Barton, J. J., & Caplan, L. R. (2012). Cerebral visual dysfunction. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139093286.007
52. Barz, H., Barz, U., & Schreiber, A. (2015). Increased Tissue Pressure Induces Demyelinated Lesions and Necroses in the Brain. Neuroscience International. https://doi.org/10.3844/amjnsp.2015.1.7
53. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
54. Baumann, A., & Sturzenegger, M. (2006). Neuropathie motrice multifocale (NMM) - Diagnostic difficile, confusion facile, traitement efficace. Forum Médical Suisse ‒ Swiss Medical Forum. https://doi.org/10.4414/fms.2006.06003
55. Bazarian, J. J., Černak, I., Noble‐Haeusslein, L. J., Potolicchio, S. L., & Temkin, N. (2009). Long-term Neurologic Outcomes After Traumatic Brain Injury. Journal of Head Trauma Rehabilitation. https://doi.org/10.1097/htr.0b013e3181c15600
56. Begué, N. M., Cobos, E., Quiñones, S. M., & Ginebreda, J. A. (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
57. Behan, P. O., Chaudhuri, A., & Hutchinson, S. (2012). Denial of compensation for patients who developed multiple sclerosis or have existing disease made worse following acute stress or trauma. Medical Law International. https://doi.org/10.1177/0968533212465614
58. Behrens, M. I., & Donoso, A. (2005). Variabilidad y variantesde la enfermedad de Alzheimer. Revista médica de Chile. https://doi.org/10.4067/s0034-98872005000400013
59. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
60. Belen, A. C. A., Josue, R. D. A., Reyna, G. M. D., Alison, B. P. S., Valencia, B. S. S., Castro, H. R. C., Gabriela, V. F. K., & Stefania, V. Q. (2023). Revisión bibliográfica: repercusiones neurológicas y nefrológicas de la Eclampsia. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv6n1-203
61. Beleza, P., Machado, Á., Soares‐Fernandes, J., Carneiro, G., Jordão, M. J., Almeida, F., & Figueiredo, J. (2008). Isolated oculomotor nerve paresis as the presenting sign of multiple sclerosis. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000200024
62. Bell, D. S. (2022). Diabetic Mononeuropathies and Diabetic Amyotrophy. Diabetes Therapy. https://doi.org/10.1007/s13300-022-01308-x
63. Benditt, D. G. (1997). Neurally Mediated Syncopal Syndromes: Pathophysiological Concepts and Clinical Evaluation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/j.1540-8159.1997.tb06211.x
64. Benoit, C., Svahn, J., Debs, R., Vandendries, C., Lenglet, T., Zyss, J., Maisonobe, T., & Viala, K. (2021). Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.12438
65. Beran, R. G. (2012). Episodic Dyscontrol, Rage, and Violence. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199796793.003.0020
66. Berchtold, N. C., & Cotman, C. W. (2008). Normal and Pathological Aging: From Animals to Humans. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-422-3_1
67. Bereda, G. (2021). Classifying Causality of an Adverse Drug Reaction: Naranjo Algorithm. International Journal of Pharmacy and Chemistry. https://doi.org/10.11648/j.ijpc.20210706.14
68. Berenberg, R. A., Pellock, J. M., DiMauro, S., Schotlan, D. L., Bonilla, E., Eastwood, A. B., Hays, A. G., Vicale, C. T., Behrens, M. M., Chutorian, A. M., & Rowland, L. P. (1977). Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome?. Annals of Neurology. https://doi.org/10.1002/ana.410010104
69. Bernard‐Valnet, R., Küntzer, T., & Vaucher, J. (2019). [Management of peripheral neuropathy in general internal medicine].. PubMed.
70. Bharadwaj, B., Ayyanar, S., & Rajkumar, R. P. (2012). Graves' disease presenting with catatonia: a probable case of encephalopathy associated with autoimmune thyroid disease. Acta Neuropsychiatrica. https://doi.org/10.1111/j.1601-5215.2012.00654.x
71. Biller, J. (2011). Cómo llegar a un diagnóstico etiológico en pacientes con amenaza de accidente cerebrovascular isquémico.
72. Binder, L. M., & Campbell, K. A. (2004). Medically Unexplained Symptoms and Neuropsychological Assessment. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390490510095
73. Bischof, M., & Bassetti, C. L. (2004). Total dream loss: A distinct neuropsychological dysfunction after bilateral PCA stroke. Annals of Neurology. https://doi.org/10.1002/ana.20246
74. Blacker, D., & Dunuwille, J. (2011). Perioperative neurological disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511736193.013
75. Bob, P., Jasová, D., & Raboch, J. (2011). Subclinical Epileptiform Process in Patients with Unipolar Depression and Its Indirect Psychophysiological Manifestations. PLoS ONE. https://doi.org/10.1371/journal.pone.0028041
76. Bolton, C. F., & Young, G. B. (2002). Renal disease and electrolyte disturbances. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316134993.125
77. Bonaventura, E., Purpura, G., Pasquariello, R., Prato, S. D., Lieto, M., Barsotti, J., Paolicelli, P. B., Cioni, G., & Tinelli, F. (2021). Complex neurodevelopmental disorder in a preterm child with unilateral cerebellar hemorrhage. Applied Neuropsychology Child. https://doi.org/10.1080/21622965.2021.1935256
78. Boon, P., Breuer, L. E. M., Grevers, E., Bernas, A., Bergmans, J., Besseling, R. M., Klooster, D., Louw, A. D., Mestrom, R., Vonck, K., Zinger, S., & Aldenkamp, A. P. (2016). Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12700
79. Boone, K. B. (2008). Fixed Belief in Cognitive Dysfunction Despite Normal Neuropsychological Scores: Neurocognitive Hypochondriasis?. The Clinical Neuropsychologist. https://doi.org/10.1080/13854040802441135
80. Bosworth, B. P., Landzberg, B. R., & McEachern, E. (2017). Neurological Manifestations of Gastrointestinal and Hepatic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0190
81. Bottas, A., Cooke, R., & Richter, M. A. (2005). Comorbidity and pathophysiology of obsessive–compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0527
82. Boulton, A. J., Vinik, A., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005). Diabetic Neuropathies. Diabetes Care. https://doi.org/10.2337/diacare.28.4.956
83. Boumpas, D. (2022). 16 Management of neuropsychiatric SLE. Abstracts. https://doi.org/10.1136/lupus-2022-la.16
84. Brigo, F. (2012). EEG features of nonconvulsive status epilepticus. Epileptic Disorders. https://doi.org/10.1684/epd.2012.0545
85. Briner, V., Müller, A., & Gebbers, J. O. (1998). [Neurosarcoidosis].. PubMed.
86. BRISBY, H. (2006). PATHOLOGY AND POSSIBLE MECHANISMS OF NERVOUS SYSTEM RESPONSE TO DISC DEGENERATION. Journal of Bone and Joint Surgery. https://doi.org/10.2106/00004623-200604002-00014
87. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
88. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
89. Bronstein, A. M., & Lempert, T. (2013). Symptoms and Syndromes in the Patient with Dizziness or Unsteadiness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199608997.003.0011
90. Brown, R., Amarnani, R., Flower, L., Manson, J., & Carr, A. (2022). 122 Neurological manifestations of haemophagocytic lymphohistiocytosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2022-abn.447
91. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
92. Bruland, P. A. (2012). Effects of Diagnosis and Evidence Type on Insanity Defense Outcomes and Juror Perceptions.
93. Brust, J. C. (1988). Vascular Dementia Is Overdiagnosed. Archives of Neurology. https://doi.org/10.1001/archneur.1988.00520310117026
94. Bryer, M. A., & Chad, D. A. (1999). SENSORY NEURONOPATHIES. The Neurologist. https://doi.org/10.1097/00127893-199903000-00004
95. Bujosa, H. B. C., Rodríguez-Montalbán, R., & Rosario-Rodríguez, A. (2017). Análisis de las Propiedades Psicométricas de la Escala Crespo-Bujosa de Síntomas Neurológicos Discretos.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7714/cnps/11.1.2012
96. Bulcke, L. V. D., & Bossche, M. V. D. (2022). 0855 A challenging case of nocturnal visual hallucinations in an elderly woman. SLEEP. https://doi.org/10.1093/sleep/zsac079.849
97. Burn, D. J., & Bates, D. (1998). Neurology and the kidney. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.65.6.810
98. BURSSENS, P., VERDONK, R., & GROESSENS, E. (2000). Het malum perforans van de diabetische voet. Tijdschrift voor Geneeskunde. https://doi.org/10.2143/tvg.56.11.1000762
99. Busby, C., & Burns, A. (2002). Differential Diagnosis of Dementia. https://doi.org/10.1002/0470846410.ch54
100. Byard, R. W. (2023). Sports-Related Deaths. CRC Press eBooks. https://doi.org/10.1201/9781003138754-42
101. Büki, B., & Tarnutzer, A. A. (2013). Central causes of vertigo, dizziness, and imbalance. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199680627.003.0009
102. Büki, B., & Tarnutzer, A. A. (2013). Dizziness as emergency. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199680627.003.0002
103. Cabib, C. (2016). Alteraciones de la excitabilidad refleja y del control motor en esclerosis múltiple.
104. Cadilha, R., Amorim, H., Pinto, M., Silveira, F., & Parada, F. (2017). An atypical and severe case of neuralgic amyotrophy. Revista da Sociedade Portuguesa de Medicina Física e de Reabilitação. https://doi.org/10.25759/spmfr.244
105. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
106. Caine, D., Halliday, G. M., JKril, J., & Harper, C. (1997). Operational criteria fortheclassification of chronic alcoholics: identification ofWemicke's encephalopathy.
107. Cairns, N. J. (2011). Neuronal Intermediate Filament Inclusion Disease. https://doi.org/10.1002/9781444341256.ch42
108. Cannon, J. A. (2016). Cognitive impairment in heart failure.
109. Caproni, S., & Colosimo, C. (2016). Movement disorders and cerebrovascular diseases: from pathophysiology to treatment. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2017.1267566
110. Caputo, L. A., & Cusimano, M. D. (2002). Atypical presentation of cauda equina syndrome.. Journal of the Canadian Chiropractic Association.
111. Caratozzolo, S., Scalvini, A., Cocchi, S., & Cassarino, S. G. (2016). Neurodegenerative and Vascular Involvement in Post Stroke Dementia. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000283
112. Carney, R. M., & Freedland, K. E. (2012). Are Somatic Symptoms of Depression Better Predictors of Cardiac Events Than Cognitive Symptoms in Coronary Heart Disease?. Psychosomatic Medicine. https://doi.org/10.1097/psy.0b013e3182405ac4
113. Carota, A. (2002). Dépression après accident vasculaire cérébral et localisation de la lésion. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2002.01317
114. Casciato, S., Mascia, A., Quarato, P. P., D’Aniello, A., Scoppetta, C., & Gennaro, G. D. (2018). Subacute cerebellar ataxia as presenting symptom of systemic lupus erythematosus.. PubMed. https://doi.org/10.26355/eurrev_201811_16279
115. Castilla‐Guerra, L., Fernández‐Moreno, M. D. C., López‐Chozas, J. M., & Fernández‐Bolaños, R. (2006). Electrolytes Disturbances and Seizures. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00861.x
116. Catolino, N. M., CAVALHEIRO, B. S., NAZIMA, K. M., BERNARDO, R. D. P., PUCPR, C. D. M. C., & Chu, B. B. R. (2019). SYSTEMIC LUPUS ERYTHEMATOSUS COMPLICATED BY CONVERSION DISORDER. Blucher Medical Proceedings. https://doi.org/10.5151/sbr2019-269
117. Celesia, G. G. (1976). Modern concepts of status epilepticus. JAMA. https://doi.org/10.1001/jama.235.15.1571
118. Celińska‐Löwenhoff, M., & Musiał, J. (2013). [Psychiatric manifestations of autoimmune diseases--diagnostic and therapeutic problems].. PubMed.
119. Ceravolo, F., Sestito, S., Falvo, F., Salpietro, V., Polizzi, A., Ruggieri, M., Bruno, M., & Concolino, D. (2016). Neurological Involvement in Inherited Metabolic Diseases: An Overview. Journal of Pediatric Biochemistry. https://doi.org/10.1055/s-0036-1582235
120. Cernovsky, Z. Z., Ferrari, J. R., & Mendonça, J. D. (2019). Deceptive Clinical Diagnosing of Malingering via Structured Inventory of Malingered Symptomatology. Archives of Psychiatry and Behavioral Sciences. https://doi.org/10.22259/2638-5201.0201009
121. Chance, P. F., Cavalier, L., Satran, D., Pellegrino, J. E., Kœnig, M., & Dobyns, W. B. (1999). Clinical Nosologic and Genetic Aspects of Joubert and Related Syndromes. Journal of Child Neurology. https://doi.org/10.1177/088307389901401007
122. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
123. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
124. Chavada, G., Blackburn, D., Dunleavy, D. L. F., Hoggard, N., Sharrack, B., Ponnusamy, S., & Price, S. O. (2011). PO.18 Guillain-Barre syndrome (GBS) presenting with posterior reversible encephalopathy syndrome. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-300645.30
125. Cheshire, W. P. (2016). Autonomic Physiology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259631.003.0035
126. Chiaramonte, R., Viglianesi, A., Messina, M., Meli, G., Meli, L., Chiaramonte, I., & Pero, G. (2009). An Interpretation of Optic Nerve Tortuosity. The Neuroradiology Journal. https://doi.org/10.1177/197140090902200403
127. Chicharro-Ciuffardi, A., González-Silva, M., Marinis-Palombo, A. D., & Gabler-Santalices, G. (2012). Psychiatric disorders secondary to nonconvulsive status epilepticus of frontal origin. Two clinical case reports.. PubMed.
128. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
129. Chrestian, N. (2020). Hereditary Neuropathy with Liability to Pressure Palsies.
130. Cianchetti, C., Pruna, D., & Ledda, M. (2013). Epileptic seizures and headache/migraine: A review of types of association and terminology. Seizure. https://doi.org/10.1016/j.seizure.2013.05.017
131. Claes, S. (2009). [Stress and depression: clinical, neurobiological and genetical perspectives].. PubMed.
132. Clauw, D. J., & Hassett, A. L. (2017). The role of centralised pain in osteoarthritis.. PubMed.
133. Cojocaru, I. M., Cojocaru, M., Siloşi, I., & Vrabie, C. D. (2010). Central Nervous System Manifestations in Rheumatic Diseases. Journal of Medical Biochemistry. https://doi.org/10.2478/v10011-010-0014-y
134. Comperat, L., Pégat, A., Honnorat, J., & Joubert, B. (2022). Autoimmune neuromyotonia. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000001104
135. Comı, G. (1997). Evoked potentials in diabetes mellitus.. PubMed.
136. Constantinescu, C. S., & Lim, S. (2018). Weakness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0044
137. Corrêa, D. G., Souza, S. R. D., Nunes, P. G. C., Coutinho, A. C., & Cruz, L. C. H. D. (2022). The role of neuroimaging in the determination of brain death. Figshare. https://doi.org/10.6084/m9.figshare.21755791
138. Corrêa, D. G., Souza, S. R. D., Nunes, P. G. C., Coutinho, A. C., & Cruz, L. C. H. D. (2022). The role of neuroimaging in the determination of brain death. Radiologia Brasileira. https://doi.org/10.1590/0100-3984.2022.0016
139. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
140. Costanza, A., Radomska, M., Zenga, F., Amerio, A., Aguglia, A., Serafini, G., Amore, M., Berardelli, I., Ojio, Y., & Nguyen, K. D. (2021). Severe Suicidality in Athletes with Chronic Traumatic Encephalopathy: A Case Series and Overview on Putative Ethiopathogenetic Mechanisms. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph18030876
141. Cretin, B., Philippi, N., Dibitonto, L., & Blanc, F. (2017). Epilepsy at the prodromal stages of neurodegenerative diseases. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0652
142. Crisan, H., Courtis, N. D., & Courtis, A. D. (2016). Persistent Postural-Perceptual Dizziness (PPPD): A systematic review of 10 yearsâ progress in diagnosis and treatment. Journal of Otology & Rhinology. https://doi.org/10.4172/2324-8785.1000290
143. CT, E., & MD, A. (2017). Neurovascular Coupling: A Unifying Theory for Post-Concussion Syndrome Treatment and Functional Neuroimaging. Journal of Neurology & Neurophysiology. https://doi.org/10.4172/2155-9562.1000454
144. Cüreoǧlu, S., FUKUSHIMA, H., Schachern, P. A., Paparella, M. M., & HARADA, T. (2005). The Effects of Type 2 Diabetes Mellitus on the Cochlear Structure in Human Temporal Bones. Otolaryngology. https://doi.org/10.1016/j.otohns.2005.05.545
145. Daher, A., Johnson, J., Kamiya-Matsuoka, C., Thomas, S. K., & Woodman, K. (2016). Neurolymphomatosis and Anti-MAG Mononeuritis Multiplex in a Patient with Two Hematologic Malignancies (P6.284). Neurology. https://doi.org/10.1212/wnl.86.16_supplement.p6.284
146. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
147. Dan, A., Voiculescu, V., Alexianu, M., Manole, E., Ionescu, M. D., Burghelea, B., & Zlătescu, N. C. (1994). Degenerative neuromuscular diseases with a late onset. Clinical, electrophysiological and morphological study.. PubMed.
148. DaSilva, J. K., & Arezzo, J. C. (2019). Use of Nerve Conduction Assessments to Evaluate Drug-Induced Peripheral Neuropathy in Nonclinical Species—A Brief Review. Toxicologic Pathology. https://doi.org/10.1177/0192623319873878
149. Davis, G. A., Kline, D. G., Spinner, R. J., Zager, E. L., Garberina, M. J., Williams, G. R., & McCrory, P. (2008). Clinics in neurology and neurosurgery of sport: peripheral nerve injury. British Journal of Sports Medicine. https://doi.org/10.1136/bjsm.2008.048231
150. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
151. Delgado, M. G., & Bogousslavsky, J. (2013). Aggravation neurologique après une crise d’épilepsie post-AVC : une paralysie de Todd persistante?.
152. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
153. Deonna, T. (2010). [Cognitive and behavioral consequences of epilepsy during the course of brain development].. PubMed.
154. Derry, C. P., & Welch, K. A. (2013). Mild traumatic brain injury and epilepsy: alcohol misuse may underpin the association. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-306267
155. Desmond, D. W., Erkinjuntti, T., Sano, M., Cummings, J. L., Bowler, J. V., Pasquier, F., Moroney, J. T., Ferris, S. H., Stern, Y., Sachdev, P. S., & Hachinski, V. (1999). The cognitive syndrome of vascular dementia: implications for clinical trials.. PubMed.
156. Desmond, D. W., Erkinjuntti, T., Sano, M., Cummings, J. L., Bowler, J. V., Pasquier, F., Moroney, J. T., Ferris, S. H., Stern, Y., Sachdev, P. S., & Hachinski, V. C. (1999). The Cognitive Syndrome of Vascular Dementia: Implications for Clinical Trials. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199912003-00005
157. Deuschle, M., & Lederbogen, F. (2002). Depression und koronare Herzerkrankung: pathogenetische Faktoren vor dem Hintergrund des Stresskonzeptes. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2002-28434
158. Dhikav, V., Kumar, P., & Anand, P. K. (2022). Cardiovascular Comorbidities and Cognitive Impairment. OBM Geriatrics. https://doi.org/10.21926/obm.geriatr.2204214
159. Dickson, D. W., & Orr, C. (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
160. Dieterich, K., Kimber, E., & Hall, J. G. (2019). Central nervous system involvement in arthrogryposis multiplex congenita: Overview of causes, diagnosis, and care. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31732
161. Ding, J. (2011). Advances on Treatment of Congenital Nephrotic Syndrome. Testowy IndexCopernicus.
162. Diop, M., Ma, J., Lee, T., & St., K. (2012). Towards Non-Invasive Bedside Monitoring of Cerebral Blood Flow and Oxygen Metabolism in Brain-Injured Patients with Near-Infrared Spectroscopy. InTech eBooks. https://doi.org/10.5772/28618
163. Dipasquale, V., Vivo, D. D., Sancetta, F., Romeo, A., Chirico, V., Lacquaniti, A., & Chimenz, R. (2015). Pseudotumor Cerebri Syndrome and Renal Diseases in the Pediatric Population. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0035-1555153
164. Domingos, A., Silva, V., Correia, C., Rocha, L., Costa, T., Faria, M., & Mota, M. C. (2021). MO1023BARDET-BIEDL SYNDROME OR SENIOR-LOKEN SYNDROME? GOING BEYOND THE OBVIOUS. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfab108.0020
165. Domínguez-Jiménez, E. D., Piña-Ramírez, B. M. O., García-Ramírez, J., Lambert-Cerda, C. O., Hoz, J. D. D. A.-D. L., & Bravo‐Oro, A. (2012). Hiperactividad simpática paroxística: Descripción de dos casos pediátricos y revisión de la literatura. DELETED.
166. Donoso, S. A., González, V. R., González, R. P., & Pugin, A. A. (2008). Demencia semántica. Presentación de dos casos y revisión de la literatura Semantic dementia: Report of two casesd*.
167. Doose, H. (1992). Myoclonic-astatic epilepsy.. PubMed.
168. Ducharme, S., Price, B. H., & Dickerson, B. C. (2017). Apathy: a neurocircuitry model based on frontotemporal dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2017-316277
169. Dumitrescu, L., Nicolau, A., & Popescu, B. O. (2013). Kaleidoscopic nervous system involvement in the setting of a chronic multisystem dysimmune disorder: report of a remarkable case. Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2013.2.4
170. Duncan, K. R. (2022). Neuropsychiatric symptoms after stroke. Current psychiatry. https://doi.org/10.12788/cp.0279
171. Dupont, C., Bougnères, P., & Baud, O. (2002). La substance blanche et la maladie cœliaque. Médecine thérapeutique / Pédiatrie.
172. Dutta, A., Paudel, R., Thapa, L. J., Bhattarai, S., Shrestha, M., & Shrestha, M. (2023). Blurred boundaries of the brain-1 (Aide-memoire for patient narrative). Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v12i1.59430
173. Dörr, S., Schickel, R., Lucke-Paulig, L., Schöntag, S., & Lobmann, R. (2019). Rapid Cognitive Decline and Recurrent Falls in a 71 Year-Old Man due to Cerebral Amyloidangiopathy-Related Inflammation (CAA-RI). Geriatrics. https://doi.org/10.3390/geriatrics4040056
174. Elkind, M. S. (2008). Endothelial repair capacity and migraine. Neurology. https://doi.org/10.1212/01.wnl.0000310647.04081.3c
175. Ellis, R. J. B., Mbizvo, G. K., Jacob, A., Doran, M., & Larner, A. J. (2016). Relapsing polychondritis complicated by cognitive dysfunction: two distinct clinical phenotypes?. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2016.1151880
176. Ellis, S., Rang, C., Kotsimbos, T., Keating, D., Finlayson, F., Stark, R., Thyagarajan, D., & Wilson, J. (2019). CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events. BMJ Open Respiratory Research. https://doi.org/10.1136/bmjresp-2019-000456
177. Elrefai, N. A. R. (2013). Anesthetic management for parturients with neurological disorders. Anesthesia Essays and Researches. https://doi.org/10.4103/0259-1162.118940
178. Elshazly, M., & Chandran, M. (2008). Catatonia, neuroleptics and brain damage – a case report. Journal of Psychopharmacology. https://doi.org/10.1177/0269881108091257
179. Emre, M. (2003). What causes mental dysfunction in Parkinson's disease?. Movement Disorders. https://doi.org/10.1002/mds.10565
180. Endres, D., Rauer, S., Venhoff, N., Süß, P., Dersch, R., Runge, K., Fiebich, B. L., Nickel, K., Matysik, M., Maier, S., Domschke, K., Egger, K., Prüß, H., & Elst, L. T. V. (2020). Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.00745
181. Enríquez-Marulanda, A., Shinchi, M., Granados, A. M., & Orozco, J. (2016). Porfiria aguda intermitente y su relación con el síndrome de encefalopatía posterior reversible: reporte de caso. Acta neurológica colombiana. https://doi.org/10.22379/anc.v32i2.1338
182. Epelbaum, S., & Dubois, B. (2013). [Subjective cognitive complaint. From anxiety to prodromal Alzheimer's disease?].. PubMed.
183. Erro, M. E., Gastón, I., & Navarro, M. C. (2008). [Movement disorders in the emergency department].. PubMed.
184. Esler, M., Lambert, É., & Alvarenga, M. (2008). Acute mental stress responses: neural mechanisms of adverse cardiac consequences. Stress and Health. https://doi.org/10.1002/smi.1205
185. Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T. R., Nielsen, G., Reuber, M., Voon, V., Stone, J., & Morgante, F. (2018). Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2018.1264
186. Falcicchio, G., Boero, G., Francavilla, T., Alicino, A., Sgobio, R., Trojano, M., & Neve, A. L. (2022). A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiology. Epilepsy & Behavior Reports. https://doi.org/10.1016/j.ebr.2022.100576
187. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
188. Fanouriakis, A., Voumvourakis, K., Papathanasiou, M., Doskas, T., Karageorgas, T., Tseronis, D., Kassara, D., Erden, A., Katsimbri, P., & Boumpas, D. (2017). FRI0269 “if it's not multiple sclerosis, look for a connective tissue disease”: atypical demyelinating disorders referred to a tertiary rheumatology centre. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-eular.6438
189. Fernández, A. B., Martín, E., Marrero, R., & Viera, D. J. (2020). Myoclonus and Recurrent Cardioinhibitory Vasovagal Syncope after Abdominal Surgery in a Critical Care Setting. World Journal of Cardiovascular Diseases. https://doi.org/10.4236/wjcd.2020.105025
190. Fernández, A., Andreina, M. M., Hornero, R., Ortiz, T., & López-Ibor, J. J. (2010). [Analysis of brain complexity and mental disorders].. PubMed.
191. Fierro, Á. D. J. L., Aparicio, S. Y. L., Morgado‐Valle, C., Beltrán‐Parrazal, L., García, L. I., Hernández‐Aguilar, M. E., Manzo, J., & Pérez-Estudillo, C. A. (2022). Trastornos de las neuronas motoras: causas, síntomas, factores de riesgo, diagnósticos y tratamientos. eNeurobiología. https://doi.org/10.25009/eb.v13i31.2599
192. Filippopulos, F., Zwergal, A., & Huppert, D. (2022). Is There an “Acquired Idiopathic Head-Shaking Nystagmus”?—A Discussion of Mechanisms and Clinical Implications Based on a Case Report. Frontiers in Neurology. https://doi.org/10.3389/fneur.2022.897012
193. Filley, C. M., & Brodtmann, A. (2011). Lacunes and cognitive decline. Neurology. https://doi.org/10.1212/wnl.0b013e31821d7563
194. Fisher, M., & Bogousslavsky, J. (1998). Textbook of Neurology.
195. Fitó, A. S., Roura, R. C., López‐Sala, A., Lluch, C. B., López, J. M., Rebollo, M., Julià, M. G., Póo, L. C., & Plana, J. C. (2011). Amnesia del desarrollo como secuela cognitiva focal de patología neonatal. Revista de Neurología. https://doi.org/10.33588/rn.52s01.2010803
196. Flanagan, E. P., Weinshenker, B. G., Krecke, K. N., & Pittock, S. J. (2015). Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000000104
197. Florman, J. E., Duffau, H., & Rughani, A. I. (2013). Lower Motor Neuron Findings after Upper Motor Neuron Injury: Insights from Postoperative Supplementary Motor Area Syndrome. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2013.00085
198. Flynn, F. G., Cummings, J. L., Scheibel, J., & Wirshing, W. C. (1989). Monosymptomatic Delusions of Parasitosis Associated With Ischemic Cerebrovascular Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198878900200303
199. Folkersma, H., Peerdeman, S. M., Visser, M. C., Vriens, E., Girbes, A. R. J., & Vandertop, W. P. (2003). [Neuromonitoring of patients following severe brain trauma].. PubMed.
200. Folkerth, R. D. (2011). Principles of Perinatal Hypoxic-Ischemic Brain Injury. Pathology Case Reviews. https://doi.org/10.1097/pcr.0b013e31822987df
201. Fragoso, Y. D., Rocha, F. B., Beloni, T. M. N., Orquiza, B., Rosa, P. B., Donadel, R. W., Aniceto, J. T., & Diniz, R. P. (2016). Driving Ability among Patients with Multiple Sclerosis: Can Legislation Be Provided on the Matter?. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.2017020023
202. Franklin, G. L., Camargo, C. H. F., Balaban, D. V., Marcon, J. M., Raskin, S., Meira, A. T., & Teive, H. (2022). Muscle Cramps Profile among Spinocerebellar Ataxias. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_942_21
203. Freeman, J. M., & Nelson, K. B. (1988). Intrapartum Asphyxia and Cerebral Palsy. PEDIATRICS. https://doi.org/10.1542/peds.82.2.240
204. Gaalen, J. V., Giunti, P., & Warrenburg, B. P. V. D. (2011). Movement disorders in spinocerebellar ataxias. Movement Disorders. https://doi.org/10.1002/mds.23584
205. Galasko, D. (1999). A CLINICAL APPROACH TO DEMENTIA WITH LEWY BODIES. The Neurologist. https://doi.org/10.1097/00127893-199909000-00002
206. Gale, R., & Rockwood, K. (2015). Dementia/Neurocognitive Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp379
207. Gales, A., Masingue, M., Millecamps, S., Giraudier, S., Grosliere, L., Adam, C., Salim, C., Navarro, V., & Nadjar, Y. (2018). Adolescence/adult onset MTHFR deficiency may manifest as isolated and treatable distinct neuro-psychiatric syndromes. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-018-0767-9
208. Galiero, R., Caturano, A., Vetrano, E., Beccia, D., Brin, C., Alfano, M. R., Salvo, J. D., Epifani, R., Piacevole, A., Tagliaferri, G., Rocco, M., Iadicicco, I., Docimo, G., Rinaldi, L., Sardu, C., Salvatore, T., Marfella, R., & Sasso, F. C. (2023). Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043554
209. Galletta, D., Confuorto, M., Lauria, I., Suarato, V., Califano, A., Mastrola, A., & Micanti, F. (2016). Association between Epilepsy and Psychogenic Non-Epileptic Seizures: A Case Report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2017.71004
210. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
211. Ganesh, A., Lyons, S., & Yiin, G. (2021). Neurological complications of Sjögren’s syndrome. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198806684.003.0019
212. Garaízar, C., & Prats-Viñas, J. M. (1998). Lesiones cerebrales de origen perinatal y prenatal tardío en el contexto neuropediátrico. Revista de Neurología. https://doi.org/10.33588/rn.26154.97360
213. Garrett, M., Merissa, N., & Scott, P. J. H. (2011). Diagnosis of Dementia Using Nuclear Medicine Imaging Modalities. InTech eBooks. https://doi.org/10.5772/25283
214. Garzoni, L., Vanoni, F., Rizzi, M., Simonetti, G. D., Simonetti, B. G., Ramelli, G. P., & Bianchetti, M. G. (2009). Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Lara D. Veeken. https://doi.org/10.1093/rheumatology/kep282
215. Gauci, S., Hosking, W., & Bruck, D. (2017). Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine. https://doi.org/10.1080/2331205x.2017.1312791
216. Gavett, B. E., Stern, R. A., Cantu, R. C., Nowinski, C. J., & McKee, A. C. (2010). Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt42
217. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
218. Genton, P., & Bureau, M. (2006). Progressive myoclonic epilepsies: myth or reality?. Epileptic Disorders. https://doi.org/10.1684/j.1950-6945.2006.tb00198.x
219. Geraldes, R., Coelho, M., Rosa, M. M., Severino, L., Castro, J., & Carvalho, M. D. (2008). Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.154583
220. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
221. Gill, R., McCoyd, M., Ruland, S., & Biller, J. (2019). Metabolic Encephalopathy - Part I. DeckerMed Medicine. https://doi.org/10.2310/im.1392
222. Gill, R., McCoyd, M., Ruland, S., & Biller, J. (2019). Metabolic Encephalopathy - Part I. DeckerMed Vascular and Endovascular Surgery. https://doi.org/10.2310/vasc.1392
223. Gill, R., McCoyd, M., Ruland, S., & Biller, J. (2019). Metabolic Encephalopathy - Part I. https://doi.org/10.2310/neuro.1392
224. Gill, S. J., & Nathanson, M. H. (2017). Central nervous system pathologies and anaesthesia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199642045.003.0081
225. Giorelli, M., Altomare, S., Aniello, M. S., Bruno, M. C., Leone, R., Liuzzi, D., Ingravallo, G., Fazio, P. D., Scarabino, T., & Tarantini, G. (2023). A very rare cause of leukoencephalopathy: Lymphomatosis cerebri. Intractable & Rare Diseases Research. https://doi.org/10.5582/irdr.2022.01134
226. Godoy, D. A., Orquera, J., & Rabinstein, A. A. (2018). Paroxysmal sympathetic hyperactivity syndrome caused by fat embolism syndrome. Revista Brasileira de Terapia Intensiva. https://doi.org/10.5935/0103-507x.20180035
227. Goertchen, R., Wiedersberg, H., Goertchen, E., & Senitz, D. (1977). [Development of current problems regarding perinatal CNS lesions from a neuropathologic viewpoint].. PubMed.
228. Gomes, R. R. (2022). An Unwonted Cause of Acute Cerebellar Ataxia in a Young Lady: A Rare Path to Lupus. Neurology & Neurotherapy Open Access Journal. https://doi.org/10.23880/nnoaj-16000169
229. Gonsalves, B. D., & Paller, K. A. (2002). Mistaken Memories: Remembering Events That Never Happened. The Neuroscientist. https://doi.org/10.1177/107385802236964
230. Goodin, D. S. (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
231. Goodwin, G. M. (1997). Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology. https://doi.org/10.1177/026988119701100204
232. Gordillo, R., Muñoz, L. H., López, E. S., Hernández, M. J., Borreguero, P. M., Méndez, M. A. R., Sánchez, V., Granados, T. G., & Burgos, R. I. Q. (2010). Trastorno bipolar en la infancia de causa orgánica. Revista de Psiquiatría Infanto-Juvenil.
233. Gordon, L. K. (2015). Paraneoplastic Syndromes in Neuro-Ophthalmology. Journal of Neuro-Ophthalmology. https://doi.org/10.1097/wno.0000000000000280
234. Gordon, M. F., & Leder, A. (2012). Serotonin Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_18
235. Gorson, K. C., & Gooch, C. L. (2015). The (mis)diagnosis of CIDP. Neurology. https://doi.org/10.1212/wnl.0000000000001838
236. Grant, I., Hunder, G. G., Homburger, H. A., & Dyck, P. J. B. (1997). Peripheral neuropathy associated with sicca complex. Neurology. https://doi.org/10.1212/wnl.48.4.855
237. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
238. Graus, F., Rojas-Marcos, I., & Reñé, R. (2000). Síndromes paraneoplásicos en otoneuroftalmología. Revista de Neurología. https://doi.org/10.33588/rn.3112.2000234
239. Grinyuk, V. V. (2015). Neurological disorders in hypertensive patients. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2015-4-57-64
240. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
241. Grool, A. M. (2012). White matters - The influence of cerebral small-vessel disease on depression, cognition and functioning.
242. Gross, B. A., Jadhav, A. P., Jovin, T., & Jankowitz, B. T. (2018). Neurointerventional “Near Morbidity”: A Candid Appraisal of an Early Case Series. Interventional Neurology. https://doi.org/10.1159/000489709
243. Grossman, J. T., Reano, K., Kondramashin, A., & Filatov, A. N. (2021). Neurosarcoidosis, Could It Be? - Case Report. Frontiers in Medical Case Reports. https://doi.org/10.47746/fmcr.2021.2408
244. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
245. Gustafson, D., & Skoog, I. (2009). Control of vascular risk factors. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575976.019
246. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
247. Gutiérrez-Manjarrez, F. A., & Ruíz‐Sandoval, J. L. (2011). Demencia con esclerosis hipocampal. A propósito de un caso con historia familiar de demencia. DELETED.
248. Gwathmey, K. (2015). Sensory neuronopathies. Muscle & Nerve. https://doi.org/10.1002/mus.24943
249. Gwathmey, K., & Kuhlman, G. M. (2017). Gluteal Compartment Syndrome with Neurologic Impairment: Report of Two Cases and Review of the Literature (P6.124). Neurology. https://doi.org/10.1212/wnl.88.16_supplement.p6.124
250. Gélinas, C., Klein, K., Naidech, A., & Skrobik, Y. (2013). Pain, Sedation, and Delirium Management in the Neurocritically Ill: Lessons Learned from Recent Research. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-0033-1342986
251. Gómez, J. R. (1998). Lesiones del nervio radial. Revista de Neurología. https://doi.org/10.33588/rn.26151.98961
252. Haan, E. H. D., Nys, G., & Zandvoort, M. J. V. (2006). Cognitive function following stroke and vascular cognitive impairment. Current Opinion in Neurology. https://doi.org/10.1097/01.wco.0000247612.21235.d9
253. Hadden, R. D. M., Lunn, M. P., & Hughes, R. A. C. (1999). Autoimmune Inflammatory Neuropathy. Journal of the Royal College of Physicians of London. https://doi.org/10.1016/s0035-8819(25)01713-1
254. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
255. Halabi, C., Williams, E. K., Morshed, R. A., Caffarelli, M., Anastasiou, C., Tihan, T., Cooke, D. L., Abla, A. A., Dowd, C. F., Shah, V., Chung, S. A., & Richie, M. (2021). Neurological manifestations of polyarteritis nodosa: a tour of the neuroaxis by case series. BMC Neurology. https://doi.org/10.1186/s12883-021-02228-2
256. Halaris, A. (2009). Comorbidity between depression and cardiovascular disease.. PubMed.
257. Halbauer, J. D., Ashford, J. W., Zeitzer, J. M., Adamson, M. M., Lew, H. L., & Yesavage, J. A. (2009). Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. The Journal of Rehabilitation Research and Development. https://doi.org/10.1682/jrrd.2008.08.0119
258. Halicka, D., Jankowicz, E., & Paprocka, K. (1998). [Subcortical dementia and the frontal lobe syndrome].. PubMed.
259. Hallman, J., & Oreland, L. (1989). Serotonergic mechanisms and psychiatric disorders. Nordisk Psykiatrisk Tidsskrift. https://doi.org/10.3109/08039488909100834
260. Hamdan, F. F., Holder, J. L., & Michaud, J. L. (2019). SYNGAP1-Related Intellectual Disability.
261. Hamed, S. A. (2018). Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2019.1555468
262. Hammond, A. (2018). i120 Activities and participation: the meaning of life. Lara D. Veeken. https://doi.org/10.1093/rheumatology/key075.120
263. Hariharan, S. (2013). A study of Clinical and Electrophysiological correlation in patients with Alcoholic Neuropathy..
264. Hasbun, R. (2022). Infections of the central nervous system. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch102
265. Hay, J., Johnson, V. E., Smith, D. H., & Stewart, W. (2016). Chronic Traumatic Encephalopathy: The Neuropathological Legacy of Traumatic Brain Injury. Annual Review of Pathology Mechanisms of Disease. https://doi.org/10.1146/annurev-pathol-012615-044116
266. Heeren, T. J., & Crevel, H. V. (1998). [Revised consensus 'Diagnosis of the dementia syndrome'].. PubMed.
267. Hehr, U., Uyanık, G., Aigner, L., Couillard‐Després, S., & Winkler, J. (2011). DCX-Related Disorders.
268. Heimer, G., Gregory, A., Hogarth, P., Hayflick, S. J., & Zeev, B. B. (2019). MECR-Related Neurologic Disorder.
269. Henderson, A. H., Hallam, M.-J., Saha, R., & Nduka, C. (2013). A case of persistent hemifacial weakness.. PubMed.
270. Hermans, M. C. E., Faber, C. G., Vanhoutte, E. K., Bakkers, M., Baets, M. H. D., Die‐Smulders, C. D., & Merkies, I. S. J. (2011). Peripheral neuropathy in myotonic dystrophy type 1. Journal of the Peripheral Nervous System. https://doi.org/10.1111/j.1529-8027.2011.00313.x
271. Hernández, S. V., Hernández, E. Z., Munari, A. F., Castañeda, O. L., & Boulton, A. J. (1994). [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment].. PubMed.
272. Hietaharju, A., Jääskeläinen, S., Hietarinta, M., & Frey, H. (2009). Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1993.tb04122.x
273. Hijdra, A., Wurff, F. B. V. D., & Weinstein, H. C. (1999). [Vascular brain damage: an important and recognizable cause of cognitive and behavioral disorders].. PubMed.
274. Hinson, H. E., & Sheth, K. N. (2012). Manifestations of the hyperadrenergic state after acute brain injury. Current Opinion in Critical Care. https://doi.org/10.1097/mcc.0b013e3283513290
275. Hirabayashi, S., Kitagawa, T., Yamamoto, I., Yamada, K., & Kawano, H. (2018). Postoperative C5 Palsy: Conjectured Causes and Effective Countermeasures. Spine Surgery and Related Research. https://doi.org/10.22603/ssrr.2018-0016
276. Hirai, M., Maeda, Y., Noyama, Y., Nakai, K., Fuji, S., Yuen, K., & Nishizaki, K. (2015). Case reports of isolated vertigo due to cerebrovascular problems, in reference to differential diagnosis with peripheral vertigo.. Equilibrium Research. https://doi.org/10.3757/jser.74.199
277. Hirsch, L. J., Fong, M., & Brenner, R. P. (2022). Post cardiac arrest patterns. https://doi.org/10.1002/9781118752883.ch8
278. Ho, J. T., & Lenggenhager, B. (2021). Neural underpinnings of body image and body schema disturbances. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198851721.003.0016
279. Hofmann, C. G., Fontana, R. S., Parker, T. D., Deutschmann, M., Dewey, M., Reinsberger, C., Claussen, M., Scherr, J., & Jeckell, A. (2021). Sports psychiatry and medical views on mild traumatic brain injury in competitive sport: a current review and recommendations. German Journal of Sports Medicine. https://doi.org/10.5960/dzsm.2021.501
280. Horváth, S. (2001). [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].. PubMed.
281. Hosseini, N., Moghaddam-Ahmadi, A., Dawarani, M. A. A., Bidaki, R., & TajikSafa, A. (2013). Prolonged Vertigo Associated with Nystagmus: an Organic or a Psychiatric Disorder? – Discussing a Case Report. Galen Medical Journal. https://doi.org/10.31661/gmj.v2i2.31
282. Hossmann, K. (1998). Experimental models for the investigation of brain ischemia. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(98)00075-3
283. Howard, R., Tan, S. V., & Z’Graggen, W. J. (2008). Weakness on the intensive care unit. Practical Neurology. https://doi.org/10.1136/jnnp.2008.157263
284. Hu, G., & Chen, Y. (2017). Post-stroke Dementia: Epidemiology, Mechanisms and Management. International journal of gerontology. https://doi.org/10.1016/j.ijge.2017.07.004
285. Huang, R., & Bi, G. (2017). [Bilateral vestibulopathy].. PubMed. https://doi.org/10.13201/j.issn.1001-1781.2017.24.018
286. Hugo, F., Heerden, B. V., Zungu‐Dirwayi, N., & Stein, D. J. (1999). Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1999)10:3<129::aid-da7>3.0.co;2-b
287. Hugo, F., Heerden, B. V., Zungu‐Dirwayi, N., & Stein, D. J. (1999). Functional brain imaging in obsessive‐compulsive disorder secondary to neurological lesions. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1999)10:3<129::aid-da7>3.3.co;2-2
288. Ibáñez, A. G., Bolumburu, E. U., & Torres, C. V. (2012). Estado epiléptico no convulsivo en el siglo XXI: clínica, diagnóstico, tratamiento y pronóstico. Revista de Neurología. https://doi.org/10.33588/rn.5402.2011250
289. Ihara, M. (2016). [Post Stroke Dementia].. PubMed. https://doi.org/10.11477/mf.1416200506
290. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
291. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
292. Ivanović, B., Šimić, D., Matić, D., Matić, S., & Zlatanović, M. (2005). Značaj psihosocijalnih faktora u nastanku i pogoršanju koronarne bolesti. Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor.
293. İbiloğlu, A. O., Atlı, A., Kaya, M. C., Baran, A. S., & Sır, A. (2016). Psychogenic Gait Disorder After a Stressful Life Event: Case Report. Turkiye Klinikleri Journal of Case Reports. https://doi.org/10.5336/caserep.2015-46732
294. Jabbari, B., & Vaziri, N. D. (2017). The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodialysis International. https://doi.org/10.1111/hdi.12587
295. Jain, K. K. (2011). Introduction. Humana Press eBooks. https://doi.org/10.1007/978-1-61779-049-2_1
296. Jain, K. K. (2019). Introduction. Springer protocols handbooks/Springer protocols. https://doi.org/10.1007/978-1-4939-9465-6_1
297. Jain, S. S., & DeLisa, J. A. (1998). 1. WHOLE MUSCLE AND SINGLE FIBER SPECIFIC FORCE. American Journal of Physical Medicine & Rehabilitation. https://doi.org/10.1097/00002060-199803000-00018
298. Jans, I. S., Oudewortel, L., Brandt, P. M., & Gool, W. A. V. (2015). Severe, Persistent and Fatal Delirium in Psychogeriatric Patients Admitted to a Psychiatric Hospital. Dementia and Geriatric Cognitive Disorders Extra. https://doi.org/10.1159/000381847
299. Jarry, V. D. M., Pereira, F. V., Dalaqua, M., Duarte, J. Á., França, M. C., & Reis, F. (2022). Common and uncommon neuroimaging manifestations of ataxia: an illustrated guide for the trainee radiologist. Part 2 - neoplastic, congenital, degenerative, and hereditary diseases. Radiologia Brasileira. https://doi.org/10.1590/0100-3984.2021.0112
300. Jeffcoate, W., Idris, I., & Game, F. L. (2004). Erythromelia, or Mitchell's syndrome – new names for unexplained signs of inflammation in distal symmetrical neuropathy in diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2004.01346.x
301. Jiang, S., Jiang, L., & Dai, L. (2006). Mechanisms of osteoporosis in spinal cord injury. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02683.x
302. Jones, L. K., Crum, B. A., Benarroch, E. E., & Brown, R. D. (2013). Neurologic Disorders Categorized by Anatomical Involvement. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199948949.003.0045
303. Josephs, K. A. (2011). Neuronal intranuclear inclusion disease. Neurology. https://doi.org/10.1212/wnl.0b013e3182166ead
304. July, J., & Guha, A. (2011). Treatment of Peripheral Nerve Tumors.
305. Jung, H. H., Danek, A., Walker, R. H., Frey, B. M., & Gassner, C. (2012). McLeod Neuroacanthocytosis Syndrome. University of Washington, Seattle eBooks. https://doi.org/10.5167/uzh-176393
306. Kahler, S. G., & Fahey, M. (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
307. Kalimo, H., & Smith, M. (1986). Structural Aspects of Ischemic Brain Damage. https://doi.org/10.1007/978-3-7091-8859-0_35
308. Kaplan, P. W., & Rossetti, A. O. (2011). EEG Patterns and Imaging Correlations in Encephalopathy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0b013e31821c33a0
309. Karlsen, B., Vedeler, C. A., & Sykehus, H. (2001). Nevromuskulære komplikasjoner ved sepsis. Tidsskrift for Den Norske Laegeforening.
310. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
311. Kastury, L. L., Golomb, J., Kluger, A., Boksay, I., Wisoff, J. H., Weiner, H. L., George, A. E., Ferris, S. H., & Reisberg, ‌. (2006). P4–140: Neuropsychologic deficits in normal pressure hydrocephalus. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2006.05.1879
312. Kaufmann, P., Pascual, J. M., Anziska, Y., Gooch, C. L., Engelstad, K., Jhung, S., DiMauro, S., & Vivo, D. C. D. (2006). Nerve Conduction Abnormalities in Patients With MELAS and the A3243G Mutation. Archives of Neurology. https://doi.org/10.1001/archneur.63.5.746
313. Kaushal, H., Sureka, R. K., Jain, J., Kaushik, Y., Wahane, M., & Chaudhary, I. (2023). Spectrum of movement disorders in liver disease: A case series. https://doi.org/10.4103/jomm.jomm_6_23
314. Kd, N., & Fröscher, W. (1994). [Psychiatric changes caused by epileptic seizures].. PubMed.
315. Keary, T. A., Galioto, R., Hughes, J. W., Waechter, D., Spitznagel, M. B., Rosneck, J., Josephson, R., & Gunstad, J. (2012). Reduced Heart Rate Recovery Is Associated with Poorer Cognitive Function in Older Adults with Cardiovascular Disease. Cardiovascular Psychiatry and Neurology. https://doi.org/10.1155/2012/392490
316. Kedia, S., & Cloninger, C. R. (2013). Personality. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139016919.021
317. Kempler, P. (2002). [Clinical presentation and diagnosis of diabetic neuropathy].. PubMed.
318. Khan, K., Patel, P., Kaur, K., & Hussain, N. (2022). Induction of seizures due to cortical hyperexcitability during a podiatric physical examination in an epileptic patient: A case report. Journal of the International Foot & Ankle Foundation. https://doi.org/10.55067/jifaf.v1i7.22
319. Khot, S., & Tirschwell, D. (2006). Long-Term Neurological Complications after Hypoxic-Ischemic Encephalopathy. Seminars in Neurology. https://doi.org/10.1055/s-2006-948323
320. Kim, D., Kim, S.-W., & Gil, H. (2022). Emotional and cognitive changes in chronic kidney disease. The Korean Journal of Internal Medicine. https://doi.org/10.3904/kjim.2021.492
321. Kim, H. Y., Jung, H. W., Lee, Y. A., Shin, C. H., Wang, K., Yang, S. W., & Cho, K. H. (2012). Diabetic Ketoacidosis and Cerebral Infarction Leading to a Diagnosis of Moyamoya Disease. Annals of Pediatric Endocrinology & Metabolism. https://doi.org/10.6065/apem.2012.17.4.253
322. King, R. H. M. (2001). The role of glycation in the pathogenesis of diabetic polyneuropathy. Molecular Pathology. https://doi.org/10.1136/mp.54.6.400
323. Kishi, T., Kawahara, H., Tanaka, T., Kaneko, Y., Tsuji, T., Kawaguchi, H., Nishio, Y., Hata, S., Kawamura, T., Sakamoto, K., Tanaka, M., & Satoh, W. (1998). Superior Mesenteric Artery Syndrome Complicating Mitochondrial Encephalopathy. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/00005176-199804000-00020
324. Kleinman, P. K., & Silvera, V. M. (2015). Abusive craniocervical junction and spinal trauma. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511862366.030
325. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
326. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
327. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
328. Kobylecki, C., Lee, L. K., & Kellett, M. (2015). Cerebral palsy, cerebellar ataxia, AIDS, phacomatosis, neuromuscular disorders, and epilepsy. CRC Press eBooks. https://doi.org/10.1201/b18585-27
329. Koga, M. (2013). Another CNS phenotype of anti-GQ1b antibody syndrome. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-305236
330. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
331. Konieczka, K., & Erb, C. (2017). Diseases potentially related to Flammer syndrome. The EPMA Journal. https://doi.org/10.1007/s13167-017-0116-4
332. Kop, W. J., & Gottdiener, J. S. (2011). The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease. https://doi.org/10.1002/9780470975138.ch1
333. Kopach, O., & Pivneva, T. (2018). Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration: neurophysiological insights into stem progenitor cell neurogenesis within a host environment. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.235224
334. Kotowicz, K., Gawęda, Ł., Misiak, B., & Frydecka, D. (2020). The role of the cognitive biases along the psychosis continuum: from pathophysiology to treatment options. Archives of Psychiatry and Psychotherapy. https://doi.org/10.12740/app/130365
335. Kotwal, A., Duggal, R., Sharma, V., Gupta, A., & Gupta, A. K. (2022). PERIPHERAL NERVOUS SYSTEM DISORDERS: A DIAGNOSTIC APPROACH. Global Journal For Research Analysis. https://doi.org/10.36106/gjra/7505767
336. Kozora, E., & Filley, C. M. (2011). Cognitive Dysfunction and White Matter Abnormalities in Systemic Lupus Erythematosus. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617711000191
337. Koçer, A. (2015). Cognitive problems related to vertebrobasilar circulation. TURKISH JOURNAL OF MEDICAL SCIENCES. https://doi.org/10.3906/sag-1403-100
338. Krägeloh‐Mann, I. (2010). Clinical outcome: neurological sequelae following preterm birth. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511712166.004
339. Kukla, U., Łabuzek, K., Chronowska, J., Krzystanek, M., & Okopień, B. (2015). [Mental disorders in digestive system diseases - internist's and psychiatrist's insight].. PubMed.
340. Kumar, A., Verma, R., & Singh, P. (2023). Cognitive Challenges in Aging: Unmasking Malignancy-Related Altered Mental States in the Elderly. International Journal of Science and Research (IJSR). https://doi.org/10.21275/sr231107141448
341. Kumar, V., Chakrabarti, S., Modi, M., & Sahoo, M. K. (2009). Late-onset obsessive compulsive disorder associated with possible gliomatosis cerebri. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622970903036846
342. Kuo, C., Tseng, H., Wu, Y., Cheng, M., Chen, P.-H., Hsieh, S., & Liu, C. (2012). Chronic Schizophrenia Comorbid with Neuropsychiatric Systemic Lupus Erythematosus. 臺灣精神醫學. https://doi.org/10.29478/tjp.201203.0007
343. Kwon, O. D. (2012). Cognitive Features of Vascular Dementia. https://doi.org/10.5772/26096
344. Köhler, S., & Verhey, F. (2011). [Cognitive deficits in late-life depression].. Tijdschrift voor psychiatrie.
345. La, M., Oi, Z., IuV, B., & Op, P. (2013). [The neurocognitive and neuropsychological testing in cardiac surgery].. PubMed.
346. Lacombe, V. A. (2015). Seizures in horses: diagnosis and classification. Veterinary Medicine Research and Reports. https://doi.org/10.2147/vmrr.s62078
347. Lacroix, M., Nguyen, C., Burns, R., Laporte, A., Rannou, F., & Feydy, A. (2022). Degenerative Lumbar Spine Disease: Imaging and Biomechanics. Seminars in Musculoskeletal Radiology. https://doi.org/10.1055/s-0042-1748912
348. Lance, E. I., Cannon, A. D., Casella, J. F., & Shapiro, B. K. (2022). Neurocognitive screening in sickle cell disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.29861
349. Landau, W. (2011). ‘Causal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysis’. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04006.x
350. Lara-Plaza, O., Solís‐Navarro, L., Rivera‐Lillo, G., & Torres‐Castro, R. (2022). Cognitive and motor performance effects of non-invasive brain stimulation in patients with traumatic brain injury: A meta-analysis of randomised controlled trials. https://doi.org/10.37766/inplasy2022.4.0067
351. Lass, P., Sławek, J., Derejko, M., & Rubello, D. (2008). Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging.. PubMed.
352. Laviano, A., Inui, A., Marks, D. L., Meguid, M. M., Pichard, C., Fanelli, F. R., & Seelaender, M. (2008). Neural control of the anorexia-cachexia syndrome. AJP Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.90252.2008
353. Lebert, F. (2004). [Vascular depression, limits of the concept].. PubMed.
354. Leitner, D., Faustin, A., Verducci, C., Friedman, D., William, C., Devore, S., Wısnıewskı, T., & Devinsky, O. (2021). Neuropathology in the North American sudden unexpected death in epilepsy registry. Brain Communications. https://doi.org/10.1093/braincomms/fcab192
355. Lemos, M., Lourenço, A., & Ribeiro, M. M. D. S. N. (2022). Psychiatric manifestations of paraneoplastic syndromes. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1698
356. Lennox, B. (2008). Neurocognition of depression. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0021
357. Leonard, B. E. (2002). Stress, norepinephrine and depression. Acta Neuropsychiatrica. https://doi.org/10.1034/j.1601-5215.2002.140403.x
358. Leone, S., Noera, G., & Bertolini, A. (2013). Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives. Current Medicinal Chemistry. https://doi.org/10.2174/092986713805076720
359. Leung, A., Bleakley, C., Loh, A. S., Saran, K., & Stewart, S. E. (2016). Pediatric Obsessive-Compulsive Disorder Exacerbation and Obstructive Hydrocephalus: A Case Report. PEDIATRICS. https://doi.org/10.1542/peds.2016-0558
360. Li, C., Lin, R., Su, C.-H., & Lin, W. (2006). Status Epilepticus as an Initial Manifestation of Neurosyphilis: A Case Report. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1016/s1607-551x(09)70330-4
361. Lima, N. K. D. C. (2018). Hypertension and cognition decline: Is there an ultimate link?. Journal of Clinical Hypertension. https://doi.org/10.1111/jch.13401
362. Limongelli, G., D‘Alessandro, R., Maddaloni, V., Rea, A., Sárközy, A., & McKenna, W. J. (2013). Skeletal muscle involvement in cardiomyopathies. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0b013e3283641c69
363. Lintingre, P.-F., Meyer, P., Pesquer, L., Poussange, N., Silvestre, A., & Dallaudière, B. (2018). The Median Nerve at the Carpal Tunnel … and Elsewhere. Journal of the Belgian Society of Radiology. https://doi.org/10.5334/jbsr.1354
364. Lis‐Święty, A., Brzeźińska-Wcisło, L., & Arasiewicz, H. (2016). Neurological abnormalities in localized scleroderma of the face and head: a case series study for evaluation of imaging findings and clinical course. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2016.1244823
365. Liu‐Ambrose, T., Nagamatsu, L. S., Handy, T. C., & Leghari, A. (2008). DOES IMPAIRED CEREBELLAR FUNCTION CONTRIBUTE TO RISK OF FALLS IN SENIORS? A PILOT STUDY USING FUNCTIONAL MAGNETIC RESONANCE IMAGING. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2008.01984.x
366. Lock, J. H., Irani, N. K., & Newman, N. J. (2020). Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan Journal of Ophthalmology. https://doi.org/10.4103/tjo.tjo_68_20
367. Loeb, C. (1989). The Lacunar Syndromes. European Neurology. https://doi.org/10.1159/000116454
368. Londoño, F. U., Franco, J. G., Franco, L. F. M., & Tobón, L. A. L. (2005). Ejes neuroendocrinos del estrés, síndrome metabólico y alteraciones psiquiátricas del síndrome de Cushing. IATREIA. https://doi.org/10.17533/udea.iatreia.4249
369. Lorusso, R., Taccone, F. S., Belliato, M., Delnoij, T., Zanatta, P., Cvetkovic, M., Davidson, M., Bělohlávek, J., Matta, N., Davis, C. F., IJsselstijn, H., Mueller, T., Muellenbach, R. M., Donker, D. W., David, P., Nardo, M. D., Vlasselaers, D., Miranda, D. D. R., & Hoskote, A. (2017). Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments. Minerva Anestesiologica. https://doi.org/10.23736/s0375-9393.17.11911-5
370. Lou, H. C., Skov, H., & HENKIKSEN, L. (1989). Intellectual Impairment with Regional Cerebral Dysfunction after Low Neonatal Cerebral Blood Flow. Acta Paediatrica. https://doi.org/10.1111/j.1651-2227.1989.tb11285.x
371. Lugovoy, A., & Knyazev, A. V. (2015). Neurotoxicity of general anesthetics: A modern view of the problem. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2015-4-78-82
372. Lullo, L. D., Ronco, C., Cozzolino, M., Selvi, A., Santoboni, F., & Bellasi, A. (2017). Type-5 Cardiorenal Syndrome (CRS-5): An up to Date. Nephrology Point of Care. https://doi.org/10.5301/napoc.5000212
373. Lunn, M. P., & Manji, H. (2008). Neuropathies. Medicine. https://doi.org/10.1016/j.mpmed.2008.10.002
374. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
375. Lévy, R., & Pillon, B. (2006). [Cognitive disorders in Parkinson's disease without dementia].. PubMed.
376. López‐Dolado, E., & Cruz, F. S. D. L. (1999). Neuromielitis óptica de Devic: análisis de siete casos. Revista de Neurología. https://doi.org/10.33588/rn.2805.98213
377. Lövblad, K., Bouchez, L., Altrichter, S., Ratib, O., Machi, P., Vargas, M. I., & Sztajzel, R. (2019). The role of advanced neuroimaging techniques in ischemic stroke prevention. Clinical and Translational Neuroscience. https://doi.org/10.1177/2514183x19881446
378. Magro‐Checa, C., Zirkzee, E. J. M., Huizinga, T., & Steup‐Beekman, G. M. (2016). Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. https://doi.org/10.1007/s40265-015-0534-3
379. Mah, L., Murari, G., Vandermorris, S., Verhoeff, N. P. L., & Herrmann, N. (2021). Characterizing the phenomenology of anxiety in older adults with subjective cognitive decline. Alzheimer s & Dementia. https://doi.org/10.1002/alz.055815
380. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
381. Mandel, S., & Brigham, C. R. (2000). Impairment Tutorial: Impairment From Neurogenic Bladder Dysfunction. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2000.janfeb06
382. Mann, J. J. (2013). The serotonergic system in mood disorders and suicidal behaviour. Philosophical Transactions of the Royal Society B Biological Sciences. https://doi.org/10.1098/rstb.2012.0537
383. Marchettini, P., Lacerenza, M., Mauri, E., & Marangoni, C. (2006). Painful Peripheral Neuropathies. Current Neuropharmacology. https://doi.org/10.2174/157015906778019536
384. Markousis‐Mavrogenis, G., Bacopoulou, F., Kolovou, G., Pons, M.-R., Giannakopoulou, A., Papavasiliou, A., Kitas, G. D., Chrousos, G. P., & Mavrogeni, S. (2022). Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review). Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2022.11506
385. Marković, N., Veljkovic, M., & Zečević-Luković, T. (2013). The treatment of neurogenic bladder dysfunction in patients with spinal cord injury. PONS - medicinski casopis. https://doi.org/10.5937/pons1304157m
386. Markowitsch, H. J., & Calabrese, P. (1996). Commonalities and Discrepancies in the Relationships between Behavioural Outcome and the Results of Neuroimaging in Brain-Damaged Patients. Behavioural Neurology. https://doi.org/10.1155/1996/978368
387. Marra, C. M. (1996). Peripheral Neuropathy. https://doi.org/10.1093/oso/9780195100365.003.0057
388. Martin, L. J. (2002). Synaptic and Neuroglial Pathobiology in Acute and Chronic Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-105-3_25
389. Martín, I. J., Freire, J. A., Ríos, M. P., Seoane, M. S., Yáñez, M. R., Sobrino, T., Brea, D., González, M. B., Leira, R., & Sánchez, J. C. (2008). Deterioro cognitivo asociado a la leucoaraiosis: fisiopatología, manifestaciones clínicas y tratamiento. Revista de Neurología. https://doi.org/10.33588/rn.4710.2008386
390. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
391. Martínez, D. D. N., Ezpeleta, D., & González, G. L. (2022). Enfermedades neurológicas y juego. Kranion. https://doi.org/10.24875/kranion.m22000027
392. Masgutova, S., Wenberg, S., & Retschler, M. (2008). MASGUTOVA METHOD OF REFLEX INTEGRATION FOR CHILDREN WITH CEREBRAL PALSY.
393. Mason, J. K. (2018). i119 Vascular rheumatology: endothelium, inflammation and imaging. Lara D. Veeken. https://doi.org/10.1093/rheumatology/key075.119
394. Masse, C., Chopard, G., Bennabi, D., Haffen, É., & Vandel, P. (2021). Cognitive functions in late life depression. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2021.0939
395. Mathis, S., Masson, G. L., Soulages, A., Duval, F., Solé, G., Boissonnot, M., Lathière, T., Bonduelle, T., Carla, L., Nadal, L., Baron, C., Balaboi, I., Ciron, J., & Vallat, J. (2019). Papilledema and Peripheral Neuropathies. The Neurologist. https://doi.org/10.1097/nrl.0000000000000250
396. Mazzotta, G., Cirulli, L. L., Sposato, M., & Serino, D. (2012). Attention deficit hyperactivity disorder secondary to lesion of the basal ganglia. World Journal of Neuroscience. https://doi.org/10.4236/wjns.2012.21007
397. McAleese, K. E., Colloby, S. J., Thomas, A., Al‐Sarraj, S., Ansorge, O., Neal, J., Roncaroli, F., Love, S., Francis, P. T., & Attems, J. (2021). Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer s & Dementia. https://doi.org/10.1002/alz.12291
398. McGowan, J. C., Shkolnikov, Y. P., Sala, J. B., & Ray, R. M. (2008). Diffuse electrical injury: Questioning the scientific basis. Conference proceedings - Canadian Conference on Electrical and Computer Engineering. https://doi.org/10.1109/ccece.2008.4564890
399. McHattie, A., & Jenkins, P. (2022). 123 The Incidence of neurological symptoms in patients with traumatic brain injuries and return to work. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2022-abn.156
400. McKnight, R., Price, J., & Geddes, J. (2019). Introduction to psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0005
401. McKnight, R., Price, J., & Geddes, J. (2019). People presenting with physical disorder. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0027
402. McMonnies, C. W. (2016). The potential role of neuropathic mechanisms in dry eye syndromes. Journal of Optometry. https://doi.org/10.1016/j.optom.2016.06.002
403. Me, Y., & Th, T. (2006). Febrile encephalopathy: challenges in management.. PubMed.
404. Meeusen, R., Cutsem, J. V., & Roelands, B. (2020). Endurance exercise‐induced and mental fatigue and the brain. Experimental Physiology. https://doi.org/10.1113/ep088186
405. Meeusen, R., Duclos, M., Foster, C., Fry, A. C., Gleeson, M., Nieman, D. C., Raglin, J. S., Rietjens, G., Steinacker, J. M., & Urhausen, A. (2013). Prevention, Diagnosis, and Treatment of the Overtraining Syndrome. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e318279a10a
406. Meinck, H., & Ringleb, P. A. (2012). Erkrankungen des Rueckenmarks.
407. Meißner, C., Oehmichen, M., & Saternus, K. (2005). Fall or Shaken: Traumatic Brain Injury in Children Caused by Falls or Abuse at Home - A Review on Biomechanics and Diagnosis. Neuropediatrics. https://doi.org/10.1055/s-2005-872812
408. Melnichenko, G. А. (1997). Лабораторная диагностика надпочечниковой недостаточности. Проблемы Эндокринологии. https://doi.org/10.14341/probl199743539-47
409. Menculini, G., Chipi, E., Paoletti, F. P., Gaetani, L., Nigro, P., Simoni, S., Mancini, A., Tambasco, N., Filippo, M. D., Tortorella, A., & Parnetti, L. (2021). Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22094440
410. Mendez, M. F. (2006). The Accurate Diagnosis of Early-Onset Dementia. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/q6j4-r143-p630-kw41
411. Mendola, F. L., Catanzaro, S., Polizzi, A., Schepis, C., Pirrone, C., Zanghì, A., Salafia, S., Ruggieri, M., Lacarrubba, F., Micali, G., Verzì, A. E., Sugarman, J., & Praticò, A. D. (2018). Nevus Sebaceous Syndrome. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0038-1667170
412. Merrison, A., & Hanna, M. G. (2009). Muscle disease: THE BARE ESSENTIALS. Practical Neurology. https://doi.org/10.1136/jnnp.2008.167171
413. Meyer, L. F., Jozef, F., Taborda, J., Brasil, M. A. A., & Valença, A. M. (2013). Cerebral calcifications and schizophreniform disorder. Jornal Brasileiro de Psiquiatria. https://doi.org/10.1590/s0047-20852013000100011
414. Meyer, N. J., & Hall, J. B. (2006). Brain dysfunction in critically ill patients--the intensive care unit and beyond.. Critical Care. https://doi.org/10.1186/cc4980
415. Miller, A. E., DeAngelis, T. M., Fabian, M., & Sand, I. K. (2018). Recurrent Ulcers and a Brainstem Lesion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190693190.003.0007
416. Miller, A., DeAngelis, T. M., Fabian, M., & Sand, I. K. (2018). A Case of Myelitis with a Positive Anticardiolipin Antibody. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190693190.003.0004
417. Miller, N. R. (2019). Optic Neuritis. Neuro-Ophthalmology. https://doi.org/10.1007/978-3-319-98455-1_1
418. Millin, M. G., Shah, S. M., & Wright, D. G. (2003). Nontraumatic Spinal Cord Emergencies. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.027
419. Milovanović, S., Ćulafić, Đ. M., Leposavić, L., & Vojinovic, V. C. (2004). Hepatic encephalopathy in consultative psychiatry: Experience with chlomethiazole. Engrami.
420. Mirski, M. A. (2005). Presentation and Pathophysiology of Seizures in the Critical Care Environment. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-841-0_1
421. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
422. Mitsikostas, D. D., Μoka, Ε., Orrillo, E., Aurilio, C., Vadalouca, A., Paladini, A., & Varrassi, G. (2022). Neuropathic Pain in Neurologic Disorders: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.22419
423. Mollenhauer, B., & Weintraub, D. (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
424. Monteleone, A. M., Steardo, L., Maj, M., & Monteleone, P. L. (2012). Depression and coronary heart disease. Clinical characteristics, pathogenetic links and treatment issues. Die Psychiatrie. https://doi.org/10.1055/s-0038-1671718
425. Morales, G. A., Guturbay, I., Olaciregui, O., Navajas, D., & Carrera, B. (2009). Neuromuscular syndromes of the critically ill. Anales del Sistema Sanitario de Navarra. https://doi.org/10.23938/assn.0519
426. Morand, A., Gauthier, K., Mazerolle, M., Pèlerin, A., Rigalleau, F., Sayette, V. D. L., Eustache, F., Desgranges, B., Huguet, P., & Régner, I. (2020). L’effet de menace du stéréotype en situation d’évaluation neuropsychologique : enjeux cliniques. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1684/nrp.2020.0607
427. Moreiras–Plaza, M., Fernández-Fleming, F., Azkárate-Ramírez, N., Garza, W. N.-D. L., Martín-Báez, I., & Hernansanz-Pérez, M. (2018). Diálisis peritoneal: ¿un factor de riesgo o de protección para la encefalopatía posterior reversible (PRES)? Revisión de la literatura. Nefrología. https://doi.org/10.1016/j.nefro.2017.03.026
428. Moreiras–Plaza, M., Fernández-Fleming, F., Azkárate-Ramírez, N., Garza, W. N.-D. L., Martín-Báez, I., & Hernansanz-Pérez, M. (2018). Peritoneal dialysis: A factor of risk or protection for posterior reversible encephalopathy syndrome? Review of the literature. Nefrología (English Edition). https://doi.org/10.1016/j.nefroe.2017.03.011
429. Moreno, T., Cortés, S., Solier, M. R. G., & Doblado, S. R. (2006). Enfermedad de Huntington: síntomas psiquiatricos no cognitivos preexistentes a los movimientos anormales. Anales de psiquiatría.
430. Moretti, R., Torre, P., Antonello, R. M., & Cazzato, G. (2005). Therapy of vascular dementia: perspectives and milestones. Therapy. https://doi.org/10.2217/14750708.2.4.649
431. Morley-Forster, P. (2006). Prevalence of Neuropathic Pain and the Need for Treatment. Pain Research and Management. https://doi.org/10.1155/2006/718098
432. Moryś, J. M., Jeżewska, M., & Korzeniewski, K. (2015). Neuropsychiatric manifestations of some tropical diseases. International Maritime Health. https://doi.org/10.5603/imh.2015.0009
433. Mos, M. D., Hoorn, E. J., Dippel, D. W., & Bommel, J. V. (2015). Uremic encephalopathy in critical care: does it exist and does renal replacement therapy improve outcome?. Intensive Care Medicine Experimental. https://doi.org/10.1186/2197-425x-3-s1-a468
434. Muir, K. W., Gamzu, E., & Lees, K. R. (1997). Clinical Aspects of Stroke and Therapeutic Strategies. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-472-6_3
435. Munglani, R. (2000). Neurobiological Mechanisms Underlying Chronic Whiplash Associated Pain: The Peripheral Maintenance of Central Sensitization. Journal of Musculoskeletal Pain. https://doi.org/10.1300/j094v08n01_14
436. Muntoni, F., & Mestroni, L. (2002). [Dilated cardiomyopathy: role of clinical and instrumental evaluation of the neuromuscular system].. PubMed.
437. Murphy, D. L., Timpano, K. R., Wheaton, M. G., Greenberg, B. D., & Miguel, E. C. (2010). Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2010.12.2/dmurphy
438. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
439. Na, K. S., Kim, S. G., Lee, S. I., & Jung, H. Y. (2012). 뇌졸중에서 우울증과 실행기능부전에 대한 고찰. Saengmul jeongsin euihag/Saengmul jeongsin uihak.
440. Naarding, P. (2005). Depression and Cerebrovascular Disease: a phenomenological study.
441. Nagaratnam, N., & Pathma‐Nathan, N. (1997). BEHAVIOURAL AND PSYCHIATRIC ASPECTS OF SILENT CEREBRAL INFARCTION. International Journal of Clinical Practice. https://doi.org/10.1111/j.1742-1241.1997.tb11416.x
442. Naidech, A. M., & Maas, M. B. (2016). Critical Care Neurology Perspective on Delirium. Seminars in Neurology. https://doi.org/10.1055/s-0036-1592318
443. Nair, N., Müller, H., Engelsmann, F., & Robitaille, Y. (1997). Psychogeriatric Clinical, Electro-Encephalographic and Autopsy Findings. Neuropsychobiology. https://doi.org/10.1159/000119398
444. Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-10-142
445. Neal, S., & Fields, K. B. (2010). Peripheral nerve entrapment and injury in the upper extremity.. PubMed.
446. Nelson, M., Andel, R., Martínková, J., Čechová, K., Marková, H., & Hort, J. (2020). Moderating Effect of Cognitive Reserve on Brain Integrity and Cognitive Performance. Innovation in Aging. https://doi.org/10.1093/geroni/igaa057.912
447. Newman, M. (2008). Anaesthesia and the brain. Southern African Journal of Anaesthesia and Analgesia. https://doi.org/10.1080/22201173.2008.10872531
448. Nisijima, K. (2012). Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s38638
449. Njiokiktjien, C. (1994). [Pediatric dysphasia. II. The current concepts of its neurobiological mechanisms].. PubMed.
450. Nobili, F., Cutolo, M., Sulli, A., Vitali, P., Vignola, S., & Rodriguez, G. (2002). Brain Functional Involvement by Perfusion SPECT in Systemic Sclerosis and Behçet's Disease. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb04241.x
451. Nogués, M., & Benarroch, E. E. (2008). Abnormalities of Respiratory Control and the Respiratory Motor Unit. The Neurologist. https://doi.org/10.1097/nrl.0b013e318173e830
452. Novak, V., & Mendell, J. R. (2001). Evaluation of the Peripheral Neuropathy Patient Using Autonomic Reflex Tests. https://doi.org/10.1093/oso/9780195133011.003.0005
453. Nowak, L., Smith, G. G., & Reyes, P. F. (2009). Dementia in a retired world boxing champion: case report and literature review.. PubMed.
454. Nucera, A., & Hachinski, V. (2017). Cerebrovascular and Alzheimer disease: fellow travelers or partners in crime?. Journal of Neurochemistry. https://doi.org/10.1111/jnc.14283
455. Nwankwo, I. E., Tomassoni, D., Amenta, F., Tayebati, S., & Traini, E. (2011). P4‐023: Pathogenesis of vascular dementia. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2011.05.2043
456. Oakley, D. A., Ward, N., Halligan, P. W., & Frackowiak, R. S. J. (2003). Differential brain activations for malingered and subjectively ‘real’ paralysis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198515548.003.0021
457. Obeyesekere, M., Klein, G. J., Modi, S., Leong‐Sit, P., Gula, L. J., Yee, R., Skanes, A. C., & Krahn, A. D. (2011). How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.111.965947
458. Oh, J., Stokes, K. A., Tyndel, F., & Freedman, M. (2010). Progressive Cognitive Decline in a Patient With Isolated Chronic Neurosarcoidosis. The Neurologist. https://doi.org/10.1097/nrl.0b013e31819f959b
459. Olazarán, J., Martı́nez, M. D., & Rábano, A. (2013). Normal pressure hydrocephalus mimicking Alzheimerâs disease: such an infrequent case?. Clinical Neuropathology. https://doi.org/10.5414/np300614
460. Olson, D. M., Westermarck, T., & Ekvall, S. W. (2005). Seizures And Epilepsy. https://doi.org/10.1093/oso/9780195165647.003.0010
461. Orsini, A., Valetto, A., Bertini, V., Esposito, M., Carli, N., Minassian, B. A., Bonuccelli, A., Peroni, D., Michelucci, R., & Striano, P. (2019). The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy. Seizure. https://doi.org/10.1016/j.seizure.2019.08.012
462. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
463. O’Brien, M. D. (2017). The Neurological Examination: Aeromedical Considerations. CRC Press eBooks. https://doi.org/10.1201/9781315238166-9
464. O’Donovan, C. A., & Carlos, R. A. (2002). Seizures and Endocrine Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-094-0_7
465. Padhi, A., Mehdi, A. M., Craig, K. J., & Fineberg, N. (2012). Current Classification of Impulse Control Disorders: Neurocognitive and Behavioral Models of Impulsivity and the Role of Personality. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195389715.013.0017
466. Pagnoux, C., & Swartz, R. H. (2017). Vasculitis of the Central Nervous System. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0099
467. Palaninathan, V., Balasubramanian, S., & Kumar, D. S. (2015). Molecular imaging and neurodegenerative disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199671618.003.0009
468. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
469. Palmer, S. C., Zwieten, A. V., Saglimbene, V., Ruospo, M., & Strippoli, G. F. (2022). Neurocognitive Disorders. https://doi.org/10.1002/9781119105954.ch75
470. Park, H. J. (2006). Motor delay : cerebral palsy. Korean Journal of Pediatrics. https://doi.org/10.3345/kjp.2006.49.10.1019
471. Passantino, A., & Masucci, M. (2016). Congenital and inherited neurologic diseases in dogs and cats: Legislation and its effect on purchase in Italy. Veterinary World. https://doi.org/10.14202/vetworld.2016.437-443
472. Patchell, R. A., Fellows, H., & Humphries, L. L. (2009). Neurologic complications of anorexia nervosa. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1994.tb01645.x
473. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
474. Perlman, J. M. (2006). Summary Proceedings From the Neurology Group on Hypoxic-Ischemic Encephalopathy. PEDIATRICS. https://doi.org/10.1542/peds.2005-0620e
475. Perlow, E., & Lucado, A. M. (2013). Persistent shoulder pain: possible visceral or systemic sources. Physical Therapy Reviews. https://doi.org/10.1179/1743288x13y.0000000129
476. Perry, M. C. (1976). The Hyperviscosity Syndrome. JAMA. https://doi.org/10.1001/jama.1976.03270040048034
477. Perry, M. C. (1976). The hyperviscosity syndrome. JAMA. https://doi.org/10.1001/jama.236.4.392
478. PETRY, A. A., COLOMBO, D., Andrade, M. A., DELFINO, J., Santos, T. A. F. G. D., & Skare, T. L. (2019). CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS CAUSING PRES (REVERSIBLE POSTERIOR ENCEPHALOPATHY SYNDROME): CASE REPORT. Blucher Medical Proceedings. https://doi.org/10.5151/sbr2019-073
479. Pham‐Scottez, A. (2016). [Medical complications of anorexia nervosa].. PubMed.
480. Phillips, K., & Clauw, D. J. (2012). Review: Central pain mechanisms in the rheumatic diseases: Future directions. Arthritis & Rheumatism. https://doi.org/10.1002/art.37739
481. Piagkou, M., Demesticha, T., Piagkos, G., Georgios, A., & Panagiotis, S. (2010). Lingual Nerve Entrapment in Muscular and Osseous Structures. International Journal of Oral Science. https://doi.org/10.4248/ijos10063
482. Picard, L. S., Lindsay, S., Strawn, J. R., Kaneria, R. M., Patel, N. C., & Keck, P. E. (2008). Atypical Neuroleptic Malignant Syndrome: Diagnostic Controversies and Considerations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.28.4.530
483. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
484. Pincherle, A., Rossi, F., Jöhr, J., Dunet, V., Ryvlin, P., Oddo, M., Schiff, N., & Diserens, K. (2020). Early discrimination of cognitive motor dissociation from disorders of consciousness: pitfalls and clues. Journal of Neurology. https://doi.org/10.1007/s00415-020-10125-w
485. Pirart, J. (1965). Diabetic Neuropathy: a Metabolic or a Vascular Disease?. Diabetes. https://doi.org/10.2337/diab.14.1.1
486. Ploteau, S., Cardaillac, C., Perrouin‐Verbe, M., Riant, T., & Labat, J.-J. (2016). Pudendal Neuralgia Due to Pudendal Nerve Entrapment: Warning Signs Observed in Two Cases and Review of the Literature.. PubMed.
487. Polinsky, R. J. (2019). Shy-Drager Syndrome and Multiple System Atrophy. CRC Press eBooks. https://doi.org/10.1201/9781315141367-6
488. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
489. Pressman, M. R. (2023). Forensic Evaluation of a Single Episode of a Disorder of Arousal in a Sleepwalking Defense: Cognitive Function Versus Prior Clinical History. Sleep Science. https://doi.org/10.1055/s-0043-1773787
490. Price, T. R. P., & Tucker, G. (1977). PSYCHIATRIC AND BEHAVIORAL MANIFESTATIONS OF NORMAL PRESSURE HYDROCEPHALUS. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-197701000-00009
491. PRYVALOVA, N., NEGREBA, T., Sukhorukov, V., & Bovt, Y. (2021). [NEUROPSYCHOLOGICAL ANALYSIS OF DISORDERS OF HIGHER MENTAL FUNCTIONS IN PATIENTS WITH DIFFERENT TYPES OF MULTIPLE SCLEROSIS].. PubMed.
492. Puyuelo, D. V., Bel, T. B., Murillo, A. B., Junquera, M. C., & Ferrer, A. S. (2021). Adversidad psicosocial y síndrome de Takotsubo.. Revista Sanitaria de Investigación.
493. Páez, F., Aviña‐Zubieta, J. A., & Galindo-Rodrı́guez, G. (1997). Rheumatic manifestations of neurologic and psychiatric diseases. Current Opinion in Rheumatology. https://doi.org/10.1097/00002281-199701000-00010
494. Quijano‐Roy, S., & Banda, M. G. D. L. (2018). Distrofias musculares congénitas. Revista Médica Clínica Las Condes. https://doi.org/10.1016/j.rmclc.2018.08.002
495. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve Mild cognitive impairment.
496. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
497. Rajakulendran, S., Pitceathly, R. D. S., Warren, J., Woodward, C., Sweeney, M. G., Hargreaves, I., Fratter, C., Heales, S., Taylor, R. W., Holton, J., Rahman, S. A., & Hanna, M. G. (2010). POG04 Multiple mitochondrial DNA deletions, cyclooxygenase-negative fibres and slowly progressive cognitive decline with psychiatric features. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.226340.126
498. Rana, A. Q., Ghouse, A. T., & Govindarajan, R. (2016). Sensory Peripheral Neuropathy. In clinical practice. https://doi.org/10.1007/978-3-319-39342-1_8
499. Rao, R. (2000). Frontal release signs in older people with peripheral vascular disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.68.1.105
500. Rasanu, T., Mehedinti, T., Hâncu, A., Alexianu, M., Damian, I., & Rasanu, I. (2010). Mitochondrial myopathies: current diagnosis (I). Romanian Journal of Neurology. https://doi.org/10.37897/rjn.2010.4.3
501. Rawas, H. M., Nassar, M. A., AbuSeer, A. A., Khan, A., Nasrulden, H. A., subhi, L. A., Baaziz, S. T., & Alhandi, M. O. (2021). Generalized Weakness in Intensive Care Unit: Review Article. Journal of the Medical Sciences (Berkala Ilmu Kedokteran). https://doi.org/10.12691/ajmsm-9-2-4
502. Rayner, G. (2019). Cognition-Related Brain Networks Underpin Cognitive, Emotional, and Somatic Symptom Dimensions of Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0012
503. Reckard, A. J., Eberman, L. E., Cleary, M. A., Doherty, J. L., & Gatens, D. (2013). Central Vestibulopathy in a Female Collegiate Basketball Player: A Case Study.
504. Reesman, J., Zabel, T. A., Wodka, E. L., Gray, R. P., Suskauer, S. J., Turin, E., Ferenc, L. M., Lin, D., Kossoff, E. H., & Comi, A. M. (2010). Neuropsychological Features and Risk Factors in Children With Sturge-Weber Syndrome: Four Case Reports. The Clinical Neuropsychologist. https://doi.org/10.1080/13854046.2010.485133
505. Reichard, J., & Zimmer‐Bensch, G. (2021). The Epigenome in Neurodevelopmental Disorders. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2021.776809
506. Reijnders, M. R., Leventer, R. J., Lee, B. H., Baralle, D., Selber, P., Paciorkowski, A. R., & Hunt, D. (2017). PURA-Related Neurodevelopmental Disorders. University of Washington, Seattle eBooks.
507. Reis, P. A., & Castro‐Faria‐Neto, H. C. (2022). Systemic Response to Infection Induces Long-Term Cognitive Decline: Neuroinflammation and Oxidative Stress as Therapeutical Targets. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2021.742158
508. Renaud, D. L. (2004). Leber’s hereditary optic neuropathy. https://doi.org/10.1093/oso/9780195177442.003.0042
509. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
510. Renjen, P. N., Priyal, P., Chaudhari, D., Mishra, A., Sahu, N., & Bhatnagar, A. (2023). STRATEGIC INFARCT AND COGNITIVE IMPAIRMENT: A NARRATIVE REVIEW. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/8215795
511. Ressler, K. J., & Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety. https://doi.org/10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
512. Richardson, S. A., & Koller, H. (1994). Mental And Mental Retardation. https://doi.org/10.1093/oso/9780195075168.003.0010
513. Riggio, S., & Jagoda, A. (2016). Concussion and its neurobehavioural sequelae. International Review of Psychiatry. https://doi.org/10.1080/09540261.2016.1220927
514. Rinetti, G., & Wong, M. (2002). Major Depression and the Autonomic Nervous System. CRC Press eBooks. https://doi.org/10.1201/9780203908891-24
515. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
516. Robinson, R. G. (2000). Depression and lesion location in stroke. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511722110.006
517. Rodrigues, P. I. J., Rocha, A. L., Custódio, S. R., Mara, G. L., Gomes, A. S. L., & Nunes, S. E. (2018). Demyelination in newly-diagnosed leprosy neuropathy. Journal of Neurology & Stroke. https://doi.org/10.15406/jnsk.2018.08.00297
518. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
519. Rollin‐Sillaire, A., Delbeuck, X., Pollet, M., Mackowiak, M., Lenfant, P., Noël, M., Façon, T., Leleu, X., Pasquier, F., & Rhun, É. L. (2013). Memory loss during lenalidomide treatment: a report on two cases. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-14-41
520. Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Leoutsakos, J., & Lyketsos, C. G. (2010). Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2535
521. Rossor, A. M., Carr, A., Devine, H., Chandrashekar, H. S., Pelayo‐Negro, A. L., Pareyson, D., Shy, M. E., Scherer, S. S., & Reilly, M. M. (2017). Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2016-313960
522. Rossor, A. M., Carr, A., Devine, H., Chandrashekar, H., Pelayo‐Negro, A. L., Pareyson, D., Shy, M. E., Scherer, S. W., & Reilly, M. M. (2017). PO204 Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2017-abn.225
523. Routray, S., Ray, R. K., Tripathy, R., & Paul, R. K. (2015). Neurocysticercosis presenting as Meningoencephalitis. International Journal of Bioassays. https://doi.org/10.21746/ijbio.2015.03.006
524. Rowbotham, M. C. (2005). Is fibromyalgia a neuropathic pain syndrome?. PubMed.
525. Rusconi, M. L., Carelli, L., Stampatori, C., & Mattioli, F. (2013). Cognitive and behavioral deficits following bilateral thalamic stroke: A longitudinal study. Neurocase. https://doi.org/10.1080/13554794.2013.826682
526. Russa, R. L., Maiese, A., Fazio, N. D., Morano, A., Bonaventura, C. D., Matteis, A. D., Fazio, V., Frati, P., & Fineschi, V. (2020). Post-Traumatic Meningitis Is a Diagnostic Challenging Time: A Systematic Review Focusing on Clinical and Pathological Features. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21114148
527. Rønning, O. M., & Thommessen, B. (2005). [Stroke: when the diagnosis is wrong].. PubMed.
528. Saadatnia, M., Sayedbonakdar, Z., Mohammadsharifi, G., & Sarrami, A. H. (2012). The necessity of stroke prevention in patients with systemic lupus erythematosus.. PubMed.
529. Sachdev, P. S. (2013). Posttraumatic Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da09
530. Sahonta, R., Sebastian, I. A., Aaron, S., Prabakhar, A. T., Arthur, A., & Pandian, J. (2022). Eye Signs in Stroke. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_157_22
531. Saidakovskiĭ, I. I., Iatskevich, I. E., & Labaĭ, E. N. (1994). [Diagnosis and tactics in multiple trauma].. PubMed.
532. Saied, Z., Zouari, R., Nabli, F., Rachdi, A., Mohamed, D. B., & Sassi, S. B. (2023). Cerebral large vessels vasculitis following Guillain-Barré syndrome as first clinical manifestations of primary Sjogren’s syndrome : a case report and review of the literature. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-3310557/v1
533. Sakakibara, R. (2023). Gastrointestinal Dysfunction in Multiple Sclerosis and Related Conditions. Seminars in Neurology. https://doi.org/10.1055/s-0043-1771462
534. Salavati, A. (2016). Assessing gross motor function, functional skills, and caregiver assistance in children with cerebral palsy (CP) and cerebral visual impairment (CVI).
535. Salinas, C. M., Stroescu, I., Nahab, F., & Stringer, A. Y. (2011). Long-term Neurocognitive and Neuroimaging Outcomes in Posterior Reversible Encephalopathy Syndrome: Two Case Reports and Implications. The Clinical Neuropsychologist. https://doi.org/10.1080/13854046.2011.628339
536. Salman, D., Vishnubala, D., Feuvre, P. L., Beaney, T., Korgaonkar, J., Majeed, A., & McGregor, A. H. (2021). Returning to physical activity after covid-19. BMJ. https://doi.org/10.1136/bmj.m4721
537. Sand, T., & Schrader, H. (2009). Narkolepsi og andre hypersomnier. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.08.0655
538. Sanna, G., Bertolaccini, M. L., & Khamashta, M. A. (2008). Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach. Current Pharmaceutical Design. https://doi.org/10.2174/138161208799316401
539. Sans, A., Colomé, R., López‐Sala, A., Boix, C. M., Muchart, J., Rebollo, M., Guitet, M., Callejón-Póo, L., & Campistol, J. (2011). Developmental amnesia as a focal cognitive sequela of a neonatal pathology.
540. Saracino, D., Allegorico, L., Barbarulo, A. M., Pollo, B., Giaccone, G., D’Amico, A., D’Incerti, L., Bugiani, O., Iorio, G. D., Sampaolo, S., & Melone, M. A. B. (2018). Neuro-Behçet’s disease presenting as an isolated progressive cognitive and behavioral syndrome. Neurocase. https://doi.org/10.1080/13554794.2018.1561898
541. Savino, E., Soavi, C., Capatti, E., Borrelli, M., Vigna, G. B., Passaro, A., & Zuliani, G. (2016). Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature. BMC Neurology. https://doi.org/10.1186/s12883-016-0693-1
542. Sawhney, S., Ramanan, A. V., & Murray, K. (2001). Central nervous system complications in two cases of juvenile onset dermatomyositis. Lara D. Veeken. https://doi.org/10.1093/rheumatology/40.11.1293
543. Scheau, C., Popa, G. A., Ghergus, A. E., Preda, E. M., Capsa, R. A., & Lupescu, I. G. (2013). Persistent repeated measurements by magnetic resonance spectroscopy demonstrate minimal hepatic encephalopathy: a case report.. PubMed.
544. Schneider, J. A., Crane, P. K., Gibbons, L. E., Dams‐O'Connor, K., Keene, D., Bennett, D. A., & Leurgans, S. E. (2018). F5‐06‐02: NON‐AD AND VASCULAR NEUROPATHOLOGIES ASSOCIATED WITH HISTORY OF TBI. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2018.06.2989
545. Schneider, L. S., & Abou‐Saleh, U. B. M. T. (2002). Neurochemistry. https://doi.org/10.1002/0470846410.ch72
546. Schuknecht, H. F. (1992). Myths in neurotology.. PubMed.
547. Schwartz, G. J., & Müller, H. (1978). Electroencephalograms and Autopsy Findings in Geropsychiatry. Journal of Gerontology. https://doi.org/10.1093/geronj/33.4.504
548. Schütze, S., Drevets, D. A., Tauber, S. C., & Nau, R. (2023). Septic encephalopathy in the elderly – biomarkers of potential clinical utility. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2023.1238149
549. Scolding, N. (2005). A -related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. https://doi.org/10.1093/brain/awh379
550. Scott, H., Martí, J., & Witte, P. (2022). Neuromuscular Disorders. CRC Press eBooks. https://doi.org/10.1201/9780429091537-35
551. Scuccato, R. (2019). [Somatization].. PubMed. https://doi.org/10.1701/3112.31007
552. Segarra, A. B., Prieto, I., Martínez‐Cañamero, M., & Ramírez‐Sánchez, M. (2020). Is there a link between depression, neurochemical asymmetry and cardiovascular function?. AIMS neuroscience. https://doi.org/10.3934/neuroscience.2020022
553. Semplicini, A., & Inverso, G. (2008). Antihypertensive treatment and cognitive function: another tempest in a P pot?. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e328306a72d
554. Series, H., & Esiri, M. M. (2012). Vascular dementia: a pragmatic review. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.110.008888
555. Shababi, M., Lorson, C. L., & Rudnik‐Schöneborn, S. (2013). Spinal muscular atrophy: a motor neuron disorder or a multi‐organ disease?. Journal of Anatomy. https://doi.org/10.1111/joa.12083
556. Shahab, H., Sonawalla, A., Khan, M. H., Qureshi, A., & Khan, A. H. (2018). Sleep Fainting: A Neurocardiogenic Entity. Cureus. https://doi.org/10.7759/cureus.3751
557. Shahar, A. M., Ngiu, C. S., Hashim, H. Z., Tan, H. J., & Periyasamy, P. (2011). No Coma, but Expressive Dysphasia with Cerebellar Signs: An Unique Presentation of Cerebral Malaria. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v40n8p382
558. Shaibani, A. (2018). Muscle Atrophy and Hypertrophy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190661304.003.0017
559. Sharma, N., & Kolekar, H. M. (2017). Diagnosis of Vascular Cognitive Impairment Using EEG. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00454.5
560. Shephard, E., Batistuzzo, M. C., Hoexter, M. Q., Stern, E., Zuccolo, P. F., Ogawa, C. Y., Silva, R. D. M. F. D., Brunoni, A. R., Costa, D. L., Doretto, V. F., Saraiva, L. C., Cappi, C., Shavitt, R. G., Simpson, H. B., Heuvel, O. A. V. D., & Miguel, E. C. (2021). Neurocircuit models of obsessive-compulsive disorder: limitations and future directions for research. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2020-1709
561. Shortland, P., & Mahns, D. A. (2016). Differing roles for parvalbumin neurons after nerve injury. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.189179
562. Shorvon, S. (2012). The Causes of Epilepsy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199659043.003.0006
563. Shouman, K., & Kupsky, W. J. (2019). Pathology of the Epilepsies. Cambridge University Press eBooks. https://doi.org/10.1017/9781108754200.004
564. Shu-yin, G. (2009). Atyptical Guillain-Barre Syndrome case analysis(attaches 4 example reports). Journal of Brain and Nervous Diseases.
565. Sibley, W. A. (1974). Diagnosis and Treatment of Epilepsy: Overview and General Principles. PEDIATRICS. https://doi.org/10.1542/peds.53.4.531
566. Silva, J. D. S., Bravalhieri, A. A. V., Velasquez, D. Z., Pegorare, A. B. G. D. S., & Decanine, D. (2016). Avaliação da Função Sexual de Mulheres Portadoras de Esclerose Múltipla e Mielopatia Associada ao HLTV-I (HAM/TSP). 12º Congresso Internacional da Rede Unida.
567. Silva, L. E. V., & Katayama, P. L. (2017). Baroreflex‐mediated sympathetic overactivation induced by mental stress in post‐traumatic stress disorder depends on the type of stressor. The Journal of Physiology. https://doi.org/10.1113/jp274859
568. Skullerud, K. (1994). [Brain injuries after transient circulatory and/or respiratory failure (cerebral hypoxic injury) in newborn infants].. PubMed.
569. Slegers, R. J., Vlis, T. A. B. V. D., Ackermans, L., Hoeben, A., Postma, A. A., Compter, I., Hoeijmakers, J. G. J., Beckervordersandforth, J., Broen, M. P. G., & Schijns, O. (2021). Myasthenia gravis after glioblastoma resection: paraneoplastic syndrome or coincidence? A unique case report and review of the literature. Acta Neurochirurgica. https://doi.org/10.1007/s00701-021-05035-3
570. Smith, H. S. (2006). Algoptosis. Journal of Neuropathic Pain & Symptom Palliation. https://doi.org/10.1300/j426v01n03_02
571. Snoeck, M., Molenaar, J., Voermans, N. C., & Engelen, B. G. V. (2016). [Overactive muscles: it can be more serious than common myalgia or cramp].. PubMed.
572. Snoeck, M., Scalco, R., Quinlivan, R. C. M., Treves, S., Laforêt, P., Jungbluth, H., & Voermans, N. C. (2016). Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?. BMJ Open Sport & Exercise Medicine. https://doi.org/10.1136/bmjsem-2016-000151
573. Sobotka, P. A., Mahfoud, F., Schlaich, M. P., Hoppe, U. C., Böhm, M., & Krum, H. (2011). Sympatho-renal axis in chronic disease. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-011-0335-y
574. Solanas, P. (2022). Convulsiones en adultos. Actualización en Medicina de Familia. https://doi.org/10.55783/amf.181034
575. Sommer, C., Cruccu, G., Anand, P., Attal, N., Baron, R., Garcı́a-Larrea, L., Haanpää, M., Jensen, T. S., Serra, J., & Treede, R. (2010). Assessment of Neuropathic Pain. https://doi.org/10.1002/9781444328394.ch8
576. Sommerkamp, M. E. B., Rodriguez, V. H. C., Advincula, A. L. E., Espinoza, B. X. M., & Ranilla, J. G. M. (2021). Síndrome de HaNDL y convulsiones: una presentación inusual. Facultad de Medicina.
577. Song, Y., Zhang, Y., Guo, P., Ge, L., Zhang, B., Liu, L., Kong, J., Chen, C., & Luo, S. (2018). Analysis of Genetic Factors in Children with Cerebral Palsy. NeuroQuantology. https://doi.org/10.14704/nq.2018.16.6.1587
578. Sonneville, R., Verdonk, F., Rauturier, C., Klein, I., Wolff, M., Annane, D., Chrétien, F., & Sharshar, T. (2013). Understanding brain dysfunction in sepsis. Annals of Intensive Care. https://doi.org/10.1186/2110-5820-3-15
579. Soriano-Barceló, J., Mota-Rodríguez, M. J., & Araúxo, A. (2012). Vascular psychosis in the elderly: response to clozapine.. PubMed.
580. Sova, M.-R., Dobrin, R., & Chiriţă, V. (2009). [Aspects regarding the incidence and prevalence of vascular dementia forms].. PubMed.
581. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
582. Stafstrom, C. E. (2006). Epilepsy: A Review of Selected Clinical Syndromes and Advances in Basic Science. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1038/sj.jcbfm.9600265
583. Stafstrom, C. E., Moshé, S. L., Swann, J. W., Nehlig, A., Jacobs, M., & Schwartzkroin, P. A. (2006). Models of Pediatric Epilepsies: Strategies and Opportunities. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00674_1.x
584. Starkstein, S., & Robinson, R. G. (1989). Affective Disorders and Cerebral Vascular Disease. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.154.2.170
585. Stevens, R. D., Sharshar, T., & Ely, E. W. (2013). Diagnosis of Brain Dysfunction. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139248822.026
586. Stevens, R. E., & Pronovost, P. J. (2006). The Spectrum of Encephalopathy in Critical Illness. Seminars in Neurology. https://doi.org/10.1055/s-2006-948325
587. Stocchetti, N. (2005). Brain and Sepsis: Functional Impairment, Structural Damage, and Markers. Anesthesia & Analgesia. https://doi.org/10.1213/01.ane.0000181337.03655.0c
588. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
589. Strippoli, G. F., Montinaro, V., Manno, C. S., Palma, M., Lepore, V., Schena, F., & Pertosa, G. B. (2002). [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related to uremia or dialysis?].. PubMed.
590. Strub, R. L. (2003). Vascular dementia.. PubMed.
591. Stuchlı́k, A., Petrásek, T., Hatalov, H., Rambousek, L., Nekovářová, T., & Valeš, K. (2012). Behavioral Tests for Evaluation of Information Processing and Cognitive Deficits in Rodent Animal Models of Neuropsychiatric Disorders. InTech eBooks. https://doi.org/10.5772/37844
592. Subhas, N., Pang, N. T. P., Chee, K. Y., Zain, N. R. M., Teng, K. L., & James, S. (2021). Case Report on a Misdiagnosed Case of Subcortical Vascular Dementia – the Importance of Sound Knowledge of Psychiatry With Proper History Taking. Archives of Psychiatry Research. https://doi.org/10.20471/dec.2021.57.02.09
593. Subramaniam, S., Blake, D. T., & Constantinidis, C. (2021). Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-210425
594. Sulistiawan, A., & Husna, E. (2016). PENGARUH TERAPI AKTIF MENGGENGGAM BOLA TERHADAP KEKUATAN OTOT PASIEN STROKE DI RSSN BUKITTINGGI. Jurnal Kesehatan. https://doi.org/10.35730/jk.v5i1.220
595. Suzuki, K. (2011). Clinical approach to atypical typer of dementia. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.51.930
596. Suzuki, Y. (2012). Mild Cognitive Impairment. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.71.385
597. Taliyan, R., Singh, G., & Sharma, P. (2012). None. International Journal of Pharmaceutical Sciences and Research. https://doi.org/10.13040/ijpsr.0975-8232.3(10).3530-42
598. Talman, L., & Pfeiffer, R. F. (2022). Movement Disorders and the Gut: A Review. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13407
599. Tamminga, C. A., Buchanan, R. W., & Gold, J. M. (1998). The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199803003-00004
600. Tay, J., Morris, R. G., & Markus, H. S. (2021). Apathy after stroke: Diagnosis, mechanisms, consequences, and treatment. International Journal of Stroke. https://doi.org/10.1177/1747493021990906
601. Tempelhoff, R., Kofke, W. A., & Dasheiff, R. M. (1997). Anesthetic Implications of Epilepsy, Status Epilepticus, and Epilepsy Surgery. Journal of Neurosurgical Anesthesiology. https://doi.org/10.1097/00008506-199710000-00011
602. Terranova, S., Kumar, J. D., & Libman, R. (2012). Posterior Reversible Encephalopathy Syndrome Mimicking a Left Middle Cerebral Artery Stroke. The Open Neuroimaging Journal. https://doi.org/10.2174/1874440001206010010
603. Testai, F. D., & Gorelick, P. B. (2010). Vascular Cognitive Impairment and Alzheimer Disease: Are These Disorders Linked to Hypertension and Other Cardiovascular Risk Factors?. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-010-6_12
604. Thach, B. T. (2008). Pathophysiology of Sudden Infant Death Syndrome. CRC Press eBooks. https://doi.org/10.3109/9781420060836-16
605. Thada, S. R., Gadda, R. B., & Pai, K. M. (2013). Nerve afflictions of maxillofacial region: a report of two cases. BMJ Case Reports. https://doi.org/10.1136/bcr-2013-201002
606. Thaisetthawatkul, P., Fernandes, J. A., Piccione, E., Truong, L., & Dyck, P. J. B. (2017). Inflammatory diabetic neuropathy: helpful diagnostic parameters (P5.132). Neurology. https://doi.org/10.1212/wnl.88.16_supplement.p5.132
607. Thatcher, J., Chang, Y., Chapman, M. N., Hovis, K., Fujita, A., Sobel, R. K., & Sakai, O. (2016). Clinical-Radiologic Correlation of Extraocular Eye Movement Disorders: Seeing beneath the Surface. Radiographics. https://doi.org/10.1148/rg.2016150227
608. Thiels, C., Köhler, C., Weigt-Usinger, K., Richterich, A., & Lücke, T. (2011). Dissociative gait disturbance versus Guillain-Barré-Syndrom -pitfalls in clinical presentation and diagnostics. Neuropediatrics. https://doi.org/10.1055/s-0031-1274099
609. Théaudin, M., Ochsner, F., Adam, C., Echaniz‐Laguna, A., Magy, L., Fayolle, D., Vicino, A., Hübers, A., & Péréon, Y. (2022). Diagnostiquer une neuropathie des petites fibres. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2022.18.779.803
610. Timour, Q., Frassati, D., Descotes, J., Chevalier, P., Christé, G., & Chahine, M. (2012). Sudden Death of Cardiac Origin and Psychotropic Drugs. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2012.00076
611. Togawa, S., Maruyama, M., Yamami, N., Nakayama, H., Shibayama, M., Kawashima, M., Shimada, K., & Mano, Y. (2006). Dissociation of neurological deficits in spinal decompression illness.. Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society.
612. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
613. Truini, A., Barbanti, P., Pozzilli, C., & Cruccu, G. (2012). A mechanism-based classification of pain in multiple sclerosis. Journal of Neurology. https://doi.org/10.1007/s00415-012-6579-2
614. Tsapakis, E. M., & Aitchison, K. J. (2008). Biological treatments: general considerations. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544125.026
615. Tsunoyama, K., Sakakibara, R., Yamaguchi, C., Uchiyama, T., Yamamoto, T., Yamanishi, T., Takahashi, O., Sugiyama, M., Kishi, M., & Ogawa, E. (2011). Pathogenesis of reduced or increased bladder sensation. Neurourology and Urodynamics. https://doi.org/10.1002/nau.20953
616. Tuomilehto, J., & Teuschl, Y. (2019). Basic Epidemiology of Stroke and Risk Assessment. Cambridge University Press eBooks. https://doi.org/10.1017/9781108659574.007
617. Underwood, C. F., Hildreth, C. M., Wyse, B. F., Boyd, R., Goodchild, A. K., & Phillips, J. K. (2016). Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?. Acta Physiologica. https://doi.org/10.1111/apha.12727
618. Unknown (2016). Neurovascular Coupling Response Dysfunction after Ischemic Stroke: The Possible Mechanism in Cognition Impairment. Journal of Experimental and Clinical Neurosciences. https://doi.org/10.13183/jecns.v3i1.17
619. Usui, K., Terada, K., & Inoue, Y. (2012). Diagnostic approach for studying epileptic seizure. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.857
620. Uzoni, A., Ciobanu, O., Sandu, E., Bugă, A. M., & Popa‐Wagner, A. (2015). Aging, inflammation and depressive behavior: a review. Reviews in Health Care. https://doi.org/10.7175/rhc.v6i2.1170
621. Vakhnina, N. N. (2017). Disturbances of gait and postural stability in chronic cerebral ischemia. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171171178-84
622. Valikova, T. A., Fyodorova, I. M., & Paimursina, N. Y. (2002). The clinical manifestations of nervous system mesenchyme syphilis. Bulletin of Siberian Medicine. https://doi.org/10.20538/1682-0363-2002-2-77-82
623. Vanaclocha, V., Sáiz‐Sapena, N., Ortiz‐Criado, J. M., & Vanaclocha, N. (2017). Peripheral Nerve Entrapment and their Surgical Treatment. InTech eBooks. https://doi.org/10.5772/67946
624. Vargha‐Khadem, F. (2001). Generalized Versus Selective Cognitive Impairments Resulting from Brain Damage Sustained in Childhood. Epilepsia. https://doi.org/10.1046/j.1528-1157.2001.00513.x
625. Varma, A., Jain, S., Majid, A., & Felice, M. D. (2018). Central and peripheral processes in headache. Current Opinion in Supportive and Palliative Care. https://doi.org/10.1097/spc.0000000000000336
626. Varney, N. R. (1994). Long-term neuropsychological sequelae of fever associated with amnesia. Archives of Clinical Neuropsychology. https://doi.org/10.1016/0887-6177(94)90022-1
627. Vasquez-Baiocchi, M. A. J., & Burneo, J. G. (2021). Epilepsias mioclónicas progresivas. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i4.3891
628. Venkataraman, R., Patodia, S., & Thiriveedhi, R. N. (2023). Thrombocytopenia in the Critically Ill: An Animal with Several Heads. Indian Journal of Critical Care Case Report. https://doi.org/10.5005/jp-journals-11006-0089
629. Ventura, P., Presicci, A., Perniola, T., Campa, M. G., & Margari, L. (2006). Mental Retardation and Epilepsy in Patients With Isolated Cerebellar Hypoplasia. Journal of Child Neurology. https://doi.org/10.1177/08830738060210091301
630. Venugopal, N., & Gopal, M. S. (2013). Migraine is a marker for systemic disease. Indian Journal of Ophthalmology. https://doi.org/10.4103/0301-4738.121094
631. Vermeulen, M., & Huizinga, T. (2006). [Neurological or psychiatric symptoms in patients with systemic lupus erythematosus (SLE): terminological problems, pathogenesis, diagnosis and therapy].. PubMed.
632. Vernino, S., & Vincent, A. (2013). Autoimmune and paraneoplastic autonomic neuropathies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0054
633. Verny, M., Boller, F., Hugonot-Diener, L., & Saxton, J. (2002). Clinical features and assessment of severe dementia. A review<sup>1</sup>. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.2002.00356.x
634. Vicino, A., Fayolle, D., Ochsner, F., Echaniz‐Laguna, A., Magy, L., Hübers, A., & Théaudin, M. (2022). Maladies musculaires de l’adulte : quand évoquer le diagnostic ?. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2022.18.779.799
635. Vizcarra, J. A., Lang, A. E., Sethi, K. D., & Espay, A. J. (2015). Vascular <scp>P</scp>arkinsonism: <scp>D</scp>econstructing a <scp>S</scp>yndrome. Movement Disorders. https://doi.org/10.1002/mds.26263
636. Vn, S., & Am, G. (1994). [The neurology of terminal states].. PubMed.
637. Voermans, N. C., Visser, M. D., Wokke, J. H. J., & Brusse, E. (2013). [Increased CK activity in serum without symptoms: further investigations often unnecessary].. PubMed.
638. Volpe, B. T. (1997). Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48390.x
639. Voshaar, R. C. O., Arts, M., Michielsen, P., Petrykiv, S., & Jonge, L. D. (2016). Treatment of Charles Bonnet Syndrome with Continuous Positive Airway Pressure in an Older Adult. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1705
640. Vuilleumier, P., Vocat, R., & Saj̈, A. (2013). Denial of Illness. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_9
641. Vukmir, R., Valeriano, J., & Oblack, A. (2023). Brain Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.027
642. Wachholz, P. A., & Masuda, P. Y. (2016). Perseveration as main symptom in dementia syndrome: case report. PAJAR - Pan-American Journal of Aging Research. https://doi.org/10.15448/2357-9641.2015.2.21996
643. WAHLUND, L. O. (2006). Neuroimaging should not be a routine investigation in all cases of suspected dementia. International Psychogeriatrics. https://doi.org/10.1017/s1041610206224773
644. Walcott, B. P., Kahle, K. T., & Simard, J. M. (2011). Novel Treatment Targets for Cerebral Edema. Neurotherapeutics. https://doi.org/10.1007/s13311-011-0087-4
645. Walker, J. S., & Abou‐Khalil, B. (2009). Seizures: Behavioral. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa507
646. Walker, U. A. (2013). SP0100 Myopathy in systemic sclerosis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-eular.1575
647. Walkley, S. U., Sikora, J., Micsenyi, M. C., Davidson, C., & Dobrenis, K. (2010). Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy. Biochemical Society Transactions. https://doi.org/10.1042/bst0381436
648. Wang, M. Y., & Sadun, A. A. (2013). Drug-Related Mitochondrial Optic Neuropathies. Journal of Neuro-Ophthalmology. https://doi.org/10.1097/wno.0b013e3182901969
649. Waters, K. A. (2010). Serotonin in the sudden infant death syndrome. Drug News & Perspectives. https://doi.org/10.1358/dnp.2010.23.9.1453626
650. Weathers, A. L. (2013). Encephalopathy (delirium) due to Systemic Disease. https://doi.org/10.1002/9781118414019.ch3
651. Weinshenker, B. G., & Mowzoon, N. (2006). Acute Treatments. CRC Press eBooks. https://doi.org/10.3109/9781420018714-15
652. Weißenborn, K., & Jones, E. A. (1997). Neurology and the liver. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.63.3.279
653. Wenning, G. K., & Quinn, N. (1994). Multisystematrophie. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1017967
654. Wenning, G. K., Kraft, E., Beck, R. O., Fowler, C. J., Mathias, C. J., Quinn, N., & Harding, A. E. (1997). Cerebellar presentation of multiple system atrophy. Movement Disorders. https://doi.org/10.1002/mds.870120121
655. Wentzlaff, S., Knauss, J., & Mohr, S. (2012). Fallbericht: Dementia Pugilistica (D.P.) bzw. chronisch traumatische Encephalopathie. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000069
656. Werring, D. J., & Camicioli, R. (2016). Vascular gait disorders. Neurology. https://doi.org/10.1212/wnl.0000000000002529
657. White, L. R., Hemmy, L. S., Flanagan, M. E., Kawas, C. H., Corrada, M. M., Edland, S. D., & Montine, T. J. (2018). P1‐111: RESISTANCE, RESERVE, AND RESILIENCE: SYSTEMS THAT DEFEND AGAINST AGE‐RELATED COGNITIVE DECLINE—OBSERVATIONS FROM THE HONOLULU‐ASIA AGING STUDY (HAAS). Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2018.06.114
658. Wieling, W., Thijs, R. D., Dijk, N. V., Wilde, A. A., Benditt, D. G., & Dijk, J. G. V. (2009). Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. https://doi.org/10.1093/brain/awp179
659. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
660. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
661. Wilmshurst, J. M., Ouvrier, R., & Ryan, M. M. (2019). Peripheral nerve disease secondary to systemic conditions in children. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756286419866367
662. Wilson, H. C., & Scolding, N. (2001). Inflammatory and Infective Disorders. https://doi.org/10.1093/oso/9780192630346.003.0017
663. Wingerchuk, D. M. (2005). Neuromyelitis Optica. Humana Press eBooks. https://doi.org/10.1385/1-59259-905-2:203
664. Winkler, P. (2006). Imaging in Tuberous Sclerosis Complex (TSC) with particular consideration of cerebral abnormalities. Neuropediatrics. https://doi.org/10.1055/s-2006-973965
665. Winter, B., Guenther, R., Ludolph, A. C., Hermann, A., Otto, M., & Wurster, C. D. (2019). Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2018-320033
666. Wolkowitz, O. M., Reus, V. I., Canick, J., LEVIN, B., & Lupien, S. (1997). Glucocorticoid Medication, Memory and Steroid Psychosis in Medical Illness. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48381.x
667. Wright, C. B., Vonsattel, J. P., Bell, K. L., & Honig, L. S. (2006). Dementia with Cerebrovascular Disease. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2006.10.dn1
668. Wu, D., & Yu, Y. (2012). Electroencephalography (EEG) and Unconsciousness. InTech eBooks. https://doi.org/10.5772/48346
669. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
670. Yamatogi, Y., & Ohtahara, S. (2003). Severe Epilepsy with Multiple Independent Spike Foci. Journal of Clinical Neurophysiology. https://doi.org/10.1097/00004691-200311000-00006
671. Yao, H. (2017). Cognitive dysfunction associated with silent brain lesions in community-dwelling elderly subjects: the Sefuri study. Nosotchu. https://doi.org/10.3995/jstroke.10496
672. Yaryura-Tobias, J. A., Neziroglu, F., & Torres-Gallegos, M. (2002). Neuroanatomical Correlates and Somatosensorial Disturbances in Body Dysmorphic Disorder. CNS Spectrums. https://doi.org/10.1017/s1092852900017934
673. Yokoyama, T., Nakamura, S., Horiuchi, E., Ishiyama, M., Kawashima, R., Nakamura, K., Hasegawa, K., & Yagishita, S. (2013). Late onset <scp>GM<sub>2</sub></scp> gangliosidosis presenting with motor neuron disease: An autopsy case. Neuropathology. https://doi.org/10.1111/neup.12088
674. Youssef, P. E. (2022). Childhood Neurologic Conditions: Movement Disorders.. PubMed.
675. Yuan, J., Peng, B., You, H., & Zhang, W. (2011). [Clinical and neuroimaging features of central nervous system impairments in acute intermittent porphyria].. PubMed.
676. Zhang, Y., Parikh, A., & Qian, S. (2017). Migraine and stroke. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2017-000077
677. Zhang, Y., Zheng, Y., Cai, M., Wu, L., & Zhang, B. (2019). Moyamoya disease presenting as thalamic infarction in a patient with neuromyelitis optica spectrum disorder. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.13106
678. Zhang, Z., & Lim, M. J. R. (2024). Incident Dementia After Spontaneous Intracerebral Hemorrhage. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-240111
679. Zhiznevskiy, D. V. (2022). The role of cognitive impairment in the development of balance disorders in cerebrovascular diseases. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro202212211251
680. Zochodne, D. W. (1999). Diabetic Neuropathies: Features and Mechanisms. Brain Pathology. https://doi.org/10.1111/j.1750-3639.1999.tb00233.x
681. Zou, H., Zhou, H., Yan, R., Yao, Z., & Lu, Q. (2022). Chronotype, circadian rhythm, and psychiatric disorders: Recent evidence and potential mechanisms. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.811771
682. Zwiernik, J., Zwiernik, B., Cebulski, Z., & Siwek, T. (2011). New symptoms in a patient with diagnosed porphyria – untypical clinical course or another disease? Extended differential diagnosis of multiple sclerosis. Polish Annals of Medicine. https://doi.org/10.1016/s1230-8013(11)70028-5
683. Özgöçmen, S., & Gür, A. (2008). Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome. Current Pharmaceutical Design. https://doi.org/10.2174/138161208799316366
684. Ünal, M., Şenakayli, Ö. C., & Serçe, K. (1996). Brain MRI findings in two cases with eclampsia. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/j.1440-1673.1996.tb00418.x
685. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.
686. Оstroumova, Т. М., & Koberskaya, N. N. (2020). Near-moderate cognitive decline. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2020-2-92-97